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TransportMost members of the large ATP-binding cassette (ABC) gene family are transporters involved in substrate trans-
location across biological membranes. In eukaryotes, ABC proteins functioning as drug transporters are located in
the plasma membrane and mediate the cellular efﬂux of a wide range of organic chemicals, with some trans-
porters also transporting certain metals. As the enhanced expression of ABC drug transporters can confer multi-
drug resistance (MDR) to cancers and multixenobiotic resistance (MXR) to organisms from polluted habitats,
these ABC family members are also referred to as MDR or MXR proteins. In mammals, ABC drug transporters
show predominant expression in tissues involved in excretion or constituting internal or external body bound-
aries, where they facilitate the excretion of chemicals and their metabolites, and limit chemical uptake and pen-
etration into “sanctuary” sites of the body. Available knowledge about ABC proteins is still limited in teleostﬁsh, a
large vertebrate group of high ecological and economic importance. Using transport activity measurements and
immunochemical approaches, early studies demonstrated similarities in the tissue distribution of ABC drug
transporters between teleosts and mammals, suggesting conserved roles of the transporters in the biochemical
defence against toxicants. Recently, the availability of teleost genome assemblies has stimulated studies of the
ABC family in this taxon. This review summarises the current knowledge regarding the genetics, functional prop-
erties, physiological function, and ecotoxicological relevance of teleostean ABC transporters. The available litera-
ture is reviewed with emphasis on recent studies addressing the tissue distribution, substrate spectrum,
regulation, physiological function and phylogenetic origin of teleostean ABC transporters.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
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When considering the interaction of organisms with the sur-
rounding chemosphere, central questions regard the mechanisms
of chemical uptake and elimination, as well as that of chemical distri-
bution between different body compartments (Van Aubel et al.,
2002). It is well documented that biotransformation crucially affects
chemical fate in ﬁsh (Schlenk et al., 2008). In contrast, the impact of
active transport across cellular membranes on chemical fate is still
incompletely understood in teleosts. While such transport mecha-
nisms likely affect bioaccumulation and toxicity of pollutants in
ﬁsh (Nichols et al., 2007), an understanding of the speciﬁc interac-
tions of environmental chemicals with transport proteins and the
ecotoxicological relevance of such interactions is currently only
beginning to emerge.
In eukaryotes, ABC (ATP-binding cassette) proteins comprise an
important group of transporters that control the movement of com-
pounds between the external environment and the internal milieu,
and between body compartments. These proteins were ﬁrst de-
scribed as biochemical factors conferring multidrug resistance
(MDR) in cancer, i.e., the resistance of tumour cells against structur-
ally and functionally unrelated cytostatic drugs (Roninson et al.,
1984; Gros et al., 1986). These MDR conferring proteins are localised
in the cell membrane and function as ATP-dependent biochemical
pumps mediating the cellular efﬂux of a diverse array of organic
chemicals and somemetals (Gottesman et al., 2002). ABC drug trans-
porters also show high expression levels in normal tissues involved
in excretion (e. g., kidney, liver) or acting as barriers (gut epithelium,
capillary endothelia forming the blood–brain barrier) (Fojo et al.,
1987; Thiebaut et al., 1987). ABC drug transporters often localise to
the apical side of polarised epithelial cells, suggesting their role in
limiting chemical uptake and enhancing chemical elimination, thus
contributing to the biochemical defence against toxicants (Leslie
et al., 2005). In support of such a role, animals lacking certain ABC
drug transporters as the result of natural or targeted mutations usu-
ally are healthy and viable, but can show marked hypersensitivity to
speciﬁc toxicants or mild pathophysiological changes reﬂecting the
impaired excretion of endogenous toxicants (Schinkel et al., 1994,
1995; Wijnholds et al., 1997; Kruh et al., 2007; Lagas et al., 2009).
Kurelec and co-workers were the ﬁrst to report the induction of
ABC transporters in marine invertebrate populations from polluted
habitats (Kurelec and Pivcevic, 1991; Kurelec et al., 1995). In analogy
to the phenomenon of MDR in cancer cells, Kurelec and colleagues
coined the term “multixenobiotic resistance (MXR) proteins” for ABC
drug efﬂux transporters in aquatic animals, reﬂecting the role of the
cellular pumps as protective factors against pollutant toxicity (Kurelec
and Pivčević, 1989; Kurelec and Pivcevic, 1991; Kurelec, 1992). While
the term “MXR proteins” is well established in aquatic toxicology, the
present review will employ the more general term “ABC drug trans-
porters” in order to avoid using different terminologies when referring
to aquatic and terrestrial animal models.First evidence for the ABC drug transporter Abcb11 (P-glycoprotein)
in teleost was provided by a molecular genetic study in winter ﬂounder
(Pleuronectes americanus) (Chan, 1992). The presence of Abcb1-like
proteins in ﬁsh was subsequently conﬁrmed in an immunohistochemi-
cal study in guppy (Poecilia reticulata) (Hemmer et al., 1995). Moreover,
P-glycoprotein-like transport activities weremeasured in isolated prox-
imal tubules from winter ﬂounder and killiﬁsh (Fundulus heteroclitus)
(Miller, 1995; Schramm et al., 1995; Sussman-Turner and Renfro,
1995). Subsequently, ABC drug transporters have been studied in a
number of tissues of different teleosts, using immunochemical detec-
tion (Hemmer et al., 1998; Cooper et al., 1999; Kleinow et al., 2000;
Albertus and Laine, 2001) and transport assays (Doi et al., 2001;
Sturm et al., 2001b; Miller et al., 2002). Recently, cDNA sequences
have been obtained for various ABC drug transporters (Zaja et al.,
2008b; Paetzold et al., 2009; Fischer et al., 2010, 2011, 2013; Loncar
et al., 2010; Popovic et al., 2010; Sauerborn Klobučar et al., 2010;
Costa et al., 2012; Diaz de Cerio et al., 2012), and the ABC gene family
has been annotated and analysed phylogenetically in zebraﬁsh (Danio
rerio) and channel catﬁsh (Ictalurus punctatus) (Annilo et al., 2006; Liu
et al., 2013). Moreover, a teleost cell line showing enhanced expression
of a speciﬁc teleost ABC drug transporter has been generated, which
enables the identiﬁcation of environmentally relevant compounds that
interact with this efﬂux pump (Caminada et al., 2008; Zaja et al.,
2008a, 2011; Smital et al., 2011).
The aim of the present review article is to summarise recent insights
into ABC transporters in teleost ﬁsh, focusing on data that have become
available since earlier reviews on the subject (Bard, 2000; Sturm and
Segner, 2005). Molecular, physiological and in vitro studies on ABC
transporters are reviewed focusing on teleosts, but also taking into
account studies on elasmobranchs where available. Since the annota-
tion of ABC drug transporters in zebraﬁsh (Annilo et al., 2006), genome
assemblies have become available in further teleost species, allowing to
draw a more complete picture of the complement of ABC drug trans-
porters present in this economically and ecologically important verte-
brate taxon. To this end, evolutionary relationships between ABC drug
efﬂux transporters from selected tetrapods and the presently seven
teleost species with available genome assemblies are presented.
1.1. Teleosts and other ﬁshes
“Fish” have been deﬁned as aquatic vertebrates having gills and
ﬁn-shaped limbs (Nelson, 2006). This deﬁnition comprises more
than half of the extant vertebrates, and includes taxa as diverse as
jawless (Agnatha), cartilaginous (Chondrichthyes) and bony ﬁshes
(Osteichthyes) (Helfman et al., 2009). The ﬁrst fossil evidence for
the Chondrichthyes, which include the elasmobranchs (sharks and
rays), dates from the early Devonian (418mya). Osteichthyes are divided
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ﬁsh), with the latter division containing the coelancanths, lungﬁsh and
tetrapods (Bone and Moore, 2008). The split between actinopterygians
and sarcopterygians has been recently dated to have taken place before
419 mya (Zhu et al., 2009). The teleost ﬁsh (Teleostei) are the most
advanced actinopterygian division containing ~27,000 living species
and account for the majority (~96%) of all living ﬁshes, including impor-
tant ﬁshery species (Helfman et al., 2009). Teleosts have probably
emerged in the Late Triassic (~200 mya) from a neopterygian ancestor
(Bone and Moore, 2008), and underwent four radiations, producing the
osteoglossomorphs (bony tongues), elopomorphs (tarpons and true
eels), ostarioclupeomorphs (herrings and minnow relatives) and ﬁnally
the Euteleostii, which constitute the most advanced and species-rich
teleost subdivision (Helfman et al., 2009).
Based on the observation that mammals often possessmultiple cop-
ies of genes present only once in invertebrates, it has been suggested
that whole genome duplications played an important role in vertebrate
evolution (Ohno, 1970). For instance, mammals possess four clusters of
Hox genes whereas only one cluster is found in the primitive chordate
amphioxus (Garcia-Fernandez andHolland, 1994). According to current
models, the ancestral chordate genome has undergone at least two
rounds of duplication in the lineage leading to the jawed vertebrates
(Aparicio, 2000; Escriva et al., 2002). While no further genome duplica-
tions appear to have occurred in the sarcopterygian and Chondrichthyes
lineages, a third whole genome duplication took place in a common
ancestor of extant teleosts (Amores et al., 1998; Taylor et al., 2001;
Jaillon et al., 2004; Steinke et al., 2006). As a result, teleost ﬁsh frequent-
ly possess duplicate copies of genes present in mammals only once
(Robinson-Rechavi et al., 2001). Complicating the situation further,
additional lineage-speciﬁc genome duplications have occurred in
particular teleost groups (Johnson et al., 1987).
Teleosts inhabit almost every imaginable marine or freshwater
habitat and pursue a wide range of trophic strategies, feeding on zoo-
plankton, benthic invertebrates, other ﬁshes, mammals, carrion, detri-
tus, phytoplankton, macroalgae or vascular plants (Helfman et al.,
2009). In comparison, elasmobranchs are typically large predators and
the majority of species is marine (Helfman et al., 2009). Ecotoxicologi-
cal, physiological and/or genomic data are available only for a limited
number of teleosts and a few elasmobranchs, usually species that can
be bred in captivity or be obtained easily. The aim of the present article
is to review the current knowledge on ABC transporters in teleost ﬁsh.
Where available, data from elasmobranchs are also considered. While
at points general patterns seem to emerge, it should be kept in mind
that only a small fraction of teleost species have been studied, and
prudence is advised regarding generalisations.
1.2. The ABC protein family
Members of the large ABC (ATP-binding cassette) gene superfamily
are characterised by conserved nucleotide binding domains and are
found in all biota (Higgins, 1992). Typical ABC proteins are ATP-
dependent transporters mediating the trafﬁcking of diverse substrates
across biological membranes (Dean et al., 2001). Some ABC proteins
function as drug transporters and have central relevance in the bio-
chemical defence against toxic chemicals (Schinkel and Jonker, 2003;
Leslie et al., 2005). Other ABC superfamily members are not trans-
porters, but have roles as ion channels, receptors or factors involved
in transcription and translation (Dean et al., 2001). The 48 human
ABC transporters known to date are divided into seven subfamilies
characterised by a high degree of sequence homology and designated
ABCA/Abca to ABCG/Abcg (Dean et al., 2001). In addition, some teleosts
possess members of an eighth subfamily called Abch initially identiﬁed
in the fruitﬂy (Dean et al., 2001; Annilo et al., 2006; Popovic et al., 2010).
Systematic names for ABC transporters consist of the subfamily
name (ABCA/Abca, ABCB/Abcb, ABCC/Abcc, …) followed by a number
denoting the protein (e.g., ABCB1/Abcb1, ABCC1/Abcc1). In some casesa further letter is added to distinguish multiple paralogues. In addition,
earlier non-systematic names given upon ﬁrst description of ABC
proteins are still common. ABC full transporters (FT) possess two
nucleotide-binding domains (NBD) and two transmembrane domains
(TMD) arranged in the N- to C-terminal order TMD1-NBD1-TMD2-
NBD2. ABC FTs are found in subfamilies A/a, B/b, and C/c, with some
ABCC/Abcc members showing an additional N-terminal TMD (termed
TMD0) (Deeley et al., 2006). ABC half transporters (HT) have only
one TMD and one NBD which are arranged in the N- to C-terminal
order TMD-NBD (subfamilies B/b and D/d) or NBD-TMD (subfamilies
G/g and h) (Dean et al., 2001). HTs are generally assumed to form
homo- or heterodimers to constitute a functional pump (Schinkel and
Jonker, 2003). The members of subfamilies E/e and F/f are not trans-
porters and lack TMDs (Dean et al., 2001).
1.3. ABC drug transporters
The contribution of ABC drug transporters to the biochemical de-
fence against toxicants is illustrated in a schematic fashion in Fig. 1.
After the passive uptake of hydrophobic organic chemicals by a
hypothetical epithelial cell, a ﬁrst line of defence is provided by ABC
transporters that pumpout hydrophobic substrates (Fig. 1). Biotransfor-
mation enzymes constitute a second level of defence by converting or-
ganic chemicals to products that are usually less toxic (Fig. 1). Phase I
biotransformation reactions involve the introduction of polar groups
into the chemical, while phase II reactions comprise conjugations with
endogenous moieties such as glutathione, sulfate or glucuronic acid.
The products of biotransformation metabolism are removed from the
cell by drug transporters accepting less hydrophobic substrates, which
include other types of ABC proteins (Fig. 1). In polarised epithelia or
endothelia, ABC drug transporters generally show a predominantly
apical localisation, resulting in directional transport into excreta or
away from sanctuary sites (Fig. 1).
All eukaryotic ABC drug transporters are active efﬂux pumps,
i.e., substrate translocation occurs from the cytosol or the cell
membrane to the extracellular space and is energetically linked to the
cleavage of ATP (Ambudkar and Cardarelli, 1997; Van Veen et al.,
2001; Bouige et al., 2002). This enables ABC pumps to transport sub-
strates against a concentration gradient. In contrast, drug transporters
of the solute carrier (SLC) superfamily depend on facilitated diffusion,
exchange or co-transport for transport (El-Sheikh et al., 2008;
Oostendorp et al., 2009). While certain SLCs and ABC transporters can
show overlaps in substrate speciﬁcity, SLC proteins are beyond the
scope of the present review.
Three ABC subfamilies, namely ABCB/Abcb, ABCC/Abcc and ABCG/
Abcg, are known to contain drug transporters, aswell as proteins having
roles unrelated to drug transport. In human, the most important ABC
drug efﬂux pumps are ABCB1 (also called MDR1 or P-glycoprotein),
ABCC1 (also known as the multidrug resistance-associated protein,
MRP1), ABCC2 (also known as MRP2 and the canalicular multispeciﬁc
organic anion transporter cMOAT) andABCG2 (also known as the breast
cancer resistance protein, BCRP) (Schinkel and Jonker, 2003; Leslie et al.,
2005). ABCB1 shows high levels of expression in hepatocytes, proximal
renal tubules, enterocytes and brain capillary endothelial cells, and
adopts an apical localisation in polarised cells (Ambudkar et al., 1999;
Gottesman et al., 2002). ABCC members acting as drug transporters
are called multidrug resistance proteins (MRPs) (Deeley et al., 2006;
Slot et al., 2011). ABCC1 is found in many tissues, showing high levels
in lung, testis, kidney, placenta and skeletal and heart muscles (Deeley
et al., 2006; Bakos and Homolya, 2007). The localisation of ABCC1 in
polarised cells is variable, being basolateral inmost cell types, but apical
in others, such as the capillary endothelial cells of the blood–brain bar-
rier (Deeley et al., 2006; Bakos and Homolya, 2007). ABCC2 always
shows an apical localisation in polarised cells and is predominantly
expressed in liver, kidney, small intestine, colon, gallbladder, placenta
and lung (Nies and Keppler, 2007). Compared to ABCC1 and ABCC2,
basolateral
Biotransformation
Phase 1 Phase 2
apical
1 2 4
1
3
4
T T
Fig. 1. ABC drug efﬂux and biotransformation metabolism in a hypothetical epithelial cell. (1) Hydrophobic chemicals (ﬁlled circles) can enter cells by passive diffusion (dashed arrows).
(2) Hydrophobic chemicals may be extruded from the cell by the active transport activity (ﬁlled arrows) of ABC transporters (T) such as ABCB1 (MDR1 P-glyoprotein) or ABCG2 (breast
cancer-related protein), which in polarised epithelia usually localise to the apical side. (3) Hydrophobic chemicals may undergo biotransformation metabolism, in which phase I usually
leads tomore polar products (open circles), while phase II involves conjugationwith endogenous anionicmoieties (triangles). (4) ABC drug transporters of theABCC subfamily (multidrug
resistance-associated proteins) mediate the cellular efﬂux of organic anions and conjugated metabolites. ABCC pumps can show an apical or basolateral localisation, depending on the
isoform. The schematic is based on the mammalian intestine and was modiﬁed from Chan (2004).
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suggest that ABCC3, 4, and 5may contribute to the biochemical defence
against toxicants (Borst et al., 2007; Kruh et al., 2007; Lagas et al., 2009).
ABCC4 parallels ABCC1 in that its localisation in polarised cells depends
on the cell type, showing a basolateral expression in hepatocytes but an
apical expression in renal proximal tubules and endothelial cells of brain
capillaries (VanAubel et al., 2002; Leggas et al., 2004). ABCG2 shows sig-
niﬁcant levels in liver, kidney and intestine, aswell as in the blood–brain
and blood–placenta barriers, where it adopts an apical localisation
(Robey et al., 2009; Vlaming et al., 2009).
ABC drug transporters generally show a broad substrate selectivity,
and substrate spectra signiﬁcantly overlap among different types of
ABC drug pumps (Schinkel and Jonker, 2003; Leslie et al., 2005). In
mammals, ABCB1 accepts a broad range of typically uncharged or mod-
erately basic amphipathic substrates (Ambudkar et al., 1999). Typical
substrates of ABCC subfamily transporters are organic anions and in-
clude chemical conjugates with glutathione, glucuronic acid or sulphate
produced in phase II biotransformationmetabolism (Deeley et al., 2006;
Slot et al., 2011). Despite the low degree of sequence homology be-
tween ABCB1 and ABCC1 (~19% amino acid identity) (Cole et al.,
1992), MDR phenotypes associated with ABCB1 and ABCC1 widely
overlap, and include resistance to anthracyclins, Vinca alkaloids and
epipodophyllotoxins (Gottesman et al., 2002). However, ABCC1 differs
from ABCB1 in that it provides only very limited protection against
taxanes and confers resistance to metalloid oxyanions (Deeley et al.,
2006). Both ABCC1 and ABCC2 transport free glutathione (GSH), and
GSH can stimulate the transport of other substrates by ABCC1 and
ABCC2 (Borst et al., 2006; Deeley and Cole, 2006). Moreover, ABCC1,
ABCC2 and homologous proteins from invertebrates can transport
metals such as cadmium,mercury and platinum, probably as complexes
with GSH (Broeks et al., 1996; Ishikawa et al., 1996; Bridges et al., 2008;
Bosnjak et al., 2009). ABCC4 and 5 are able to transport cyclicnucleotides, as well as drugs that are nucleoside and nucleotide
analogues (Deeley et al., 2006; Borst et al., 2007). ABCG2 overlaps in
substrate selectivity with both ABCB1 and ABCCs (Krishnamurthy and
Schuetz, 2006; Robey et al., 2009). In addition, ABCG2 mediates the
biliary excretion of porphyrin precursors, limits the gut uptake of photo-
toxic chlorophyll breakdown products (Jonker et al., 2002) and contrib-
utes to renal urate secretion (Woodward et al., 2011).
2. Genetic evidence for ABC drug transporters in ﬁsh
ABC transporters have previously been annotated from the zebraﬁsh
genome, the ﬁrst ﬁsh genome that was comprehensively sequenced
(Dean and Annilo, 2005; Annilo et al., 2006). Moreover, the ABC gene
family has been analysed in a transcriptome of the catﬁsh (Ictalurus
punctatus) generated by RNA-seq (Liu et al., 2013). The zebraﬁsh ge-
nome contains members of ABC subfamilies A to G known from tetra-
pods, as well as one transporter of subfamily H (Annilo et al., 2006).
While the presence of an abch gene has been also conﬁrmed for green
spotted puffer (Tetraodon nigroviridis), no member of this subfamily
has been retrieved in catﬁsh (Liu et al., 2013). The identiﬁcation of
zebraﬁsh homologues to human ABCB1, ABCC1–5 and ABCG2 conﬁrmed
the presence of all major vertebrate ABC drug transporters in teleosts.
However, for some tetrapod ABC drug transporters, several isoforms
were found in zebraﬁsh, complicating the assignment of function
(Annilo et al., 2006). Since the annotation of zebraﬁsh ABC transporters
(Annilo et al., 2006), assembled genome sequences have become avail-
able for a number of further ﬁsh species. In order to base the discussion
of the presence or absence of speciﬁc ABC transporters in ﬁsh on the full
range of currently available data, we consider here ABC transporter se-
quences from seven actinopterygian species with available genome as-
semblies (zebraﬁsh Danio rerio, medaka Oryzias latipes, stickleback
Gasterosteus aculeatus, fugu Takifugu rubripes, green spotted puffer
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niloticus) and the sarcopterygian species coelacanth (Latimeria
chalumnae). Fish sequences of ABC subfamilies containing drug
transporters were subjected to phylogenetic analyses together with
transporters from human and chicken.
2.1. ABCB/Abcb subfamily
The ABCB/Abcb subfamily contains both FTs and HTs, of which the
latter locate to intracellular membranes and have evolutionarilyFig. 2. Phylogenetic analysis of vertebrate ABCB/Abcb subfamily full transporters. Amino acid s
Oreochromis niloticus, Oryzias latipes, Takifugu rubripes, Tetraodon nigroviridis) and further verteb
for accession numbers)were alignedusing theprogrammeTCoffee (Notredame et al., 2000) and
software MEGA5 (Tamura et al., 2011). The percentage concordance based on 1000 bootstrap
and minimum evolution methods had very similar topologies (data not shown), indicating thaconserved physiological roles unrelated to drug transport (Abele and
Tampé, 2006; Burke and Ardehali, 2007; Herget and Tampé, 2007),
with evidence for drug transport existing only for ABCB/Abcb FTs
(Gottesman et al., 2002; Leslie et al., 2005). Therefore, our evolutionary
analyses of vertebrate ABCB/Abcb proteins excluded HTs, focusing on
ABCB/Abcb FTs.
In the obtained tree, ABCB1/Abcb1 and ABCB4/Abcb4 sequences
form a well-supported clade, within which the teleost sequences
group together in a subcluster of high bootstrap support, opposing
sarcopterygian ABCB1/Abcb1 and ABCB4/Abcb4 sequences (Fig. 2).equences of transporters from teleosts (Danio rerio, Gasterosteus aculeatus, Gadus morhua,
rates (Latimeria chalumnae,Xenopus tropicalis,Gallus gallus andHomo sapiens) (see Table S1
a phylogenetic tree constructedusing theneighbor-joiningmethodas implemented in the
iterations is shown at the nodes. Trees obtained with the alternative maximum likelihood
t the results are robust.
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MDR1 P-glycoprotein, whereas human ABCB4 is a biliary phospholipid
transporter (Ambudkar et al., 1999; Oude Elferink and Paulusma,
2007). The topology of the tree suggests that human ABCB1 and
ABCB4 arose from a lineage-speciﬁc gene duplication and that the
teleost sequences are, despite their names, not one-to-one orthologues
to either ABCB1 or ABCB4, but co-orthologues to both (Fig. 2). All teleost
species possess at least one transporter in the teleost Abcb1/Abcb4
clade, with individual sequences being named “Abcb1-like,” “Abcb4-
like” or “Abcb4” by automatic and/or synteny-based annotation. The
teleostean Abcb1/Abcb4 clade includes zebraﬁsh Abcb4 (Fischer et al.,
2013), previously annotated as Abcb1b (Annilo et al., 2006), but
excludes zebraﬁsh Abcb5, previously annotated as Abcb1a (Annilo
et al., 2006; Fischer et al., 2013) (see below). Some teleost species,
such as japanese pufferﬁsh (Takifugu rubripes) and green spotted
pufferﬁsh (Tetraodon nigroviridis), possess two P-glycoprotein genes
that based on synteny have been designated as Abcb1 and Abcb4
(Fischer et al., 2013) (Fig. 2).
An earlier study proposed that ABCB4 arose in the mammalian line-
age, and that birds and teleosts lack functional orthologues to ABCB4
(Annilo et al., 2006). Indeed, no phospholipids are detectable in bile
ﬂuid from teleosts and elasmobranch ﬁshes, indicating the lack of he-
patic ABCB4-like transport activity (Goto et al., 2003; Oude Elferink
et al., 2004; Moschetta et al., 2005). Phosphatidylcholine translocation
thus appears to be a speciﬁc, relatively recent function of mammalian
ABCB4, whereas the property of transport of a wide range of toxic
compounds by mammalian ABCB1 is more ancient. In support of this
notion, it is well documented that teleosts possess ABCB1-like transport
activities (Miller, 1995; Schramm et al., 1995; Sussman-Turner and
Renfro, 1995), which have been shown to coincide with the expres-
sion of abcb1/4 (Tutundjian et al., 2002; Zaja et al., 2008b; Fischer
et al., 2013). Recent studies provide insights into the molecular
identity of teleost ABCB1-like transporters. The characterisation of
topminnow (Poeciliopsis lucida) Abcb1 using a cell line overexpress-
ing the transporter demonstrated that this ABC pump constitutes a
multidrug transporter (Zaja et al., 2008a, 2011). Evidence for a sim-
ilar function of zebraﬁsh Abcb4 was obtained by morpholino knock-
down studies in embryos and recombinant expression studies
(Fischer et al., 2013).
In the phylogenetic analysis of vertebrate ABCB/Abcb proteins
(Fig. 2), ABCB5/Abcb5 proteins formed two clusters. The function of
ABCB5, the most recently isolated human ABCB protein, is still unclear
(Frank et al., 2003; Frank and Frank, 2009). While an initial report
found ABCB5 homologues to be lacking in zebraﬁsh (Annilo et al.,
2006), a later study proposed that the zebraﬁsh gene initially annotated
as abcb1a is actually an ABCB5 orthologue, and suggested renaming
the gene abcb5 (Fischer et al., 2013). An abcb5 gene has further been
reported from catﬁsh (Liu et al., 2013), but orthologues to ABCB5 appear
to be absent in medaka, stickleback, fugu, green spotted puffer, cod and
tilapia (Fig. 2). While gene knockdown studies in embryos did not pro-
vide evidence for a multidrug transporter function of the zebraﬁsh
Abcb5 orthologue (Fischer et al., 2013), hepatic transcript expression
of abcb5 is induced by the main zebraﬁsh bile acid cyprinol sulphate
(Reschly et al., 2007), suggesting potential roles of Abcb5 related to bil-
iary excretion. On the other hand, mRNA expression of zebraﬁsh abcb5
in embryo epidermal cells (Thisse and Thisse, 2004) parallels epidermal
ABCB5 expression in mammals where it has been suggested that this
protein regulatesmembrane potential and cell fusion of skin progenitor
cells (Frank et al., 2003).
All vertebrates considered in the evolutionary analysis of the ABCB/
Abcb subfamily possess at least one abcb11 gene (Fig. 2). Abcb11 was
originally isolated in winter ﬂounder (Chan, 1992) and regarded a po-
tential drug transporter. However, later studies showed that ABCB11/
abcb11 encodes the hepatic bile salt export pump (BSEP) (Gerloff
et al., 1998; Stieger et al., 2007). The cloning and functional characteri-
sation of Abcb11 in the elasmobranch Raja erinacea (Cai et al., 2001)demonstrated transport activity with taurocholate, suggesting the func-
tional conservation of Abcb11 across the vertebrates.
2.2. ABCC/Abcc subfamily
The ABCC/Abcc subfamily is large and complex, containing both
transporters and proteins with other roles. ABCC1 and ABCC2 are
well-studied drug efﬂux transporters (Schinkel and Jonker, 2003;
Leslie et al., 2005). While ABCC3–5 and ABCC10 and 11 are capable of
drug transport in vitro, little further evidence exists for roles of
ABCC10 and 11 as factors in the biochemical defence against toxicants
(Deeley et al., 2006; Slot et al., 2011). A number of vertebrates possess
a further MRP (Mrp10/Abcc13), which has undergone pseudo-
genisation in human (Annilo and Dean, 2004; Annilo et al., 2006).
ABCC proteins that are not transporters include the cystic ﬁbrosis trans-
membrane conductance regulator (CFTR, also called ABCC7), which is
a chloride channel, and the sulfonylurea receptors (SUR1, SUR2,
also called ABCC8 and ABCC9, respectively), which are regulators of po-
tassium channels (Riordan et al., 1989; Hibino and Kurachi, 2006;
Aleksandrov et al., 2007; Bryan et al., 2007). Moreover, ABCC6 and
ABCC12 are likely not drug transporters (Slot et al., 2011). Loss-of-
function mutations of human ABCC6 are associated with a rare genetic
disorder called PXE (pseudoxanthoma elasticum) (Bergen et al.,
2007). ABCC12 is a protein of unknown function expressed in testicular
germ cells and sperm (Ono et al., 2007).
An evolutionary analysis of the vertebrate ABCC/Abcc family was
ﬁrst carried out taking into account all members (Fig. S1). In the obtain-
ed phylogenetic tree, ABCC/Abcc proteins grouped into distinct clusters
corresponding to individual isoforms (Fig. S1), suggesting that the
divergence of different ABCC/abcc paralogues is likely ancient and has
occurred in a common ancestor of vertebrates. All teleosts studied had
at least one Abcc6, Abcc7 (CFTR), Abcc8 (SUR1) and Abcc9 (SUR2)
member, and orthologues of each of these non-drug transporter
ABCCs/Abccs formed well supported clades (Fig. S1). A distinct clade
with high bootstrap support was also formed by ABCC10/Abcc10mem-
bers, whereas proteins labelled ABCC11/Abcc11 and ABCC12/Abcc12
combined in one clade (Fig. S1). In order to obtain a tree of manageable
size, the analysis was re-run with the main drug-transporting ABCC/
Abcc isoforms, ABCC1-5/Abcc1-5 (Fig. 3). Each of the available teleost
genomes contains one orthologue of each Abcc1-3 and Abcc5, whereas
in some teleost species there aremultiple isoforms of Abcc4 (Fig. 3). The
occurrence of different numbers of isoforms in the different teleost spe-
cies raises questions about their speciﬁc functions, towhich extent func-
tions of the isoforms differ and whether functions of certain isoforms
are homologous across species. A cDNA encoding an Abcc2 homologue
was isolated from rainbow trout liver (Zaja et al., 2008b).mRNA expres-
sion proﬁles of abcc isoforms in rainbow trout (Oncorhynchus mykiss)
are generally comparable to those of their counterparts in mammals
(Loncar et al., 2010). Previously, an Abcc2 homologue had been cloned
from the elasmobranch small skate (Raja erinacea), where it showed
apical expression in liver, kidney and intestine, paralleling the tissue
distribution and localisation of ABCC2 in mammals (Cai et al., 2003).
2.3. ABCG/Abcg subfamily
The ABCG/Abcg subfamily contains the drug transporter ABCG2/
Abcg2, as well as members involved in sterol metabolism (ABCG/
Abcg1, 4, 5 and 8) (Wang et al., 2004; Hazard and Patel, 2007). In
phylogenetical analyses, all teleost Abcg sequences could be clearly afﬁl-
iated to one of the above ABCG paralogues (Fig. S2). To obtain a tree of
manageable size, the analysis was rerun including ABCG2/Abcg2 homo-
logues only (Fig. 4). Teleosts show duplications of abcg2, with two
isoforms being present in medaka, stickleback, tilapia, green puffer and
pufferﬁsh, and four in cod and zebraﬁsh (Fig. 4). In synteny analyses,
human ABCG2 showed synteny to abcg2a of green puffer and
to abcg2d of zebraﬁsh, but not to the remaining abcg2 homologues of
Gasterosteus aculeatus Abcc1
Oreochromis niloticus Abcc1
Oryzias latipes Abcc1
Takifugu rubripes Abcc1
Tetraodon nigroviridis Abcc1
Danio rerio Abcc1
Xenopus tropicalis ABCC1
Latimeria chalumnae Abcc1
Gallus gallus ABCC1
Homo sapiens ABCC1
Homo sapiens ABCC3
Gallus gallus ABCC3
Xenopus tropicalis ABCC3
Danio rerio Abcc3
Gadus morhua Abcc3
Oryzias latipes Abcc3
Oreochromis niloticus Abcc3
Gasterosteus aculeatus Abcc3
Takifugu rubripes Abcc3
Tetraodon nigroviridis Abcc3
Gallus gallus ABCC2
Xenopus tropicalis ABCC2
Homo sapiens ABCC2
Latimeria chalumnae Abcc2
Danio rerio Abcc2
Gadus morhua Abcc2
Takifugu rubripes Abcc2
Tetraodon nigroviridis Abcc2
Gasterosteus aculeatus Abcc2
Oreochromis niloticus Abcc2
Oryzias latipes Abcc2
Gallus gallus ABCC5
Homo sapiens ABCC5
Xenopus tropicalis ABCC5
Danio rerio Abcc5
Oryzias latipes Abcc5
Gasterosteus aculeatus Abcc5
Oreochromis niloticus Abcc5
Takifugu rubripes Abcc5
Tetraodon nigroviridis Abcc5
Oryzias latipes Abcc4b
Gasterosteus aculeatus Abcc4c
Oreochromis niloticus Abcc4c
Takifugu rubripes Abcc4c
Tetraodon nigroviridis Abcc4d
Gallus gallus ABCC4
Homo sapiens ABCC4
Xenopus tropicalis ABCC4
Gasterosteus aculeatus Abcc4a
Oreochromis niloticus Abcc4b
Oryzias latipes Abcc4a
Takifugu rubripes Abcc4a
Tetraodon nigroviridis Abcc4c
Gadus morhua Abcc4b
Gadus morhua Abcc4a
Danio rerio Abcc4
Gasterosteus aculeatus Abcc4b
Oreochromis niloticus Abcc4a
Takifugu rubripes Abcc4b
Tetraodon nigroviridis Abcc4a
Tetraodon nigroviridis Abcc4b
Homo sapiens ABCB1 Outgroup
100
100
84
98
100
100
100
99
100
75
100
100
100
79
100
99
83
52
67
99
100
99
56
57
99
100
69
80
51
100
100
36
99
97
100
95
84
100
86
100
100
99
100
65
97
90
100
100
100
100
100
91
87
100
100
100
100
0.05
Abcc2
Abcc5
Abcc4
Abcc1
Abcc3
Fig. 3. Phylogenetic analysis of vertebrate ABCC1-5/Abcc1-5 transporters. Included in the
analysis are transporter amino acid sequences from teleosts (Danio rerio, Gasterosteus
aculeatus, Gadusmorhua, Oreochromis niloticus, Oryzias latipes, Takifugu rubripes, Tetraodon
nigroviridis) and other vertebrates. For further details see the legend of Fig. 2.
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pufferﬁsh and in cod resembled that in green puffer, with Abcg2a
being the only Abcg2 isoforms showing synteny to ABCG2 (data not
shown).3. Functional activity and expression of ABC drug transporters in ﬁsh
Themeasurement of transport activity of ABC drug transporters usu-
ally involves monitoring the translocation of a conveniently detectable
model substrate in a suitable in vitro model (Calcagno et al., 2007).
Parallel treatments with inhibitors are included to conﬁrm the identity
of the involved transporters. Results obtained with model substrates
and inhibitors need to be interpreted with caution, as different classes
of ABC pumps overlap in substrate and inhibitor speciﬁcity (Calcagno
et al., 2007). Moreover, the assumed speciﬁcities of “selective” com-
pounds have usually been established in mammalian systems and
may not necessarily apply in ﬁsh. The speciﬁcities of themost common-
ly used substrates and inhibitors are brieﬂy reviewed here to provide
the background for the understanding of speciﬁc ﬁndings in ﬁsh
reviewed below.
A number of substrates initially described as selective for ABCB1 have
later been shown to interact with other ABC transporters. For instance,
the ﬂuorescent ABCB1 substrates rhodamine 123 and doxorubicin are
also transported by ABCC1 (Barrand et al., 1993; Twentyman et al.,
1994; Yeheskely-Hayon et al., 2009). Doxorubicin was further shown
to be also transported by ABCG2, which further interacts with the
ABCB1 substrate Hoechst 33342 (Robey et al., 2004; Krishnamurthy
and Schuetz, 2006). Calcein-acetoxymethyl ester (Calcein-AM) is a
non-charged non-ﬂuorescent substrate for both ABCB1 and ABCCs.
After cellular uptake, calcein-AM undergoes enzymatic hydrolysis to
the anionic ﬂuorophore calcein, which is transported by ABCCs but not
ABCB1 (Essodaigui et al., 1998). Pheophorbide a is regarded a speciﬁc
substrate of ABCG2 (Robey et al., 2004). In order to obtain selective
probes for particular ABC transporters, ﬂuorescent derivatives of drug
substrates have been prepared (Calcagno et al., 2007). BODIPY-FL-
verapamil, initially regarded as selective for ABCB1, has been shown to
also be transported by ABCC1 (Crivellato et al., 2002). Fluorescein-
methotrexate is regarded a speciﬁc substrate of ABCC transporters
(Masereeuw et al., 2000), whereas ﬂuo-cAMP has been described as a
speciﬁc probe for ABCC4 (Reichel et al., 2007).
The different classes of ABC transporters also overlap regarding their
speciﬁcity to inhibitors. The inhibitors verapamil and cyclosporin A
interact with both ABCB1 and ABCCs (Barrand et al., 1993; Zaman
et al., 1994), with median effective concentrations only slightly lower
in ABCB1-overexpressing cell lines than in cells showing increased
levels of ABCC1 (Holló et al., 1996). Compared to the parent compound,
the cyclosporin A derivative PSC-833 shows an improved but not com-
plete speciﬁcity towards ABCB1 (Leier et al., 1994). The compound
tariquidar has been shown to inhibit both ABCB1 and ABCG2 (Gardner
et al., 2009). Inhibitors described as speciﬁc for ABCB1 include
LY335979 (Shepard et al., 2003) and the hydrophobic peptides reversin
121 and 205 (Sharom et al., 1999). The leukotriene LTD4 receptor antag-
onist MK571 is a speciﬁc inhibitor of ABCC transporters (Gekeler et al.,
1995), whereas fumitremorgin C and Ko134 have been described as
selective ABCG2 inhibitors (Allen et al., 2002; Robey et al., 2004).
Different types of teleost tissue preparations have been used for
transport measurements. Polarised epithelia can be mounted in Ussing
chambers, allowing to establish rates of basolateral-to-apical and
apical-to-basolateral substrate translocation under different conditions
(Sussman-Turner and Renfro, 1995). In a number of marine teleosts,
isolated kidney tubules reseal spontaneously in vitro, so that the uptake
ofﬂuorescent substrates from cell culturemedia and their secretion into
the tubular lumen can be observed using confocal microscopy (Miller,
1987). In non-differentiated cells, ABC drug transporter activities can
be established as the difference in substrate accumulation between par-
allel treatments differing in the presence or absence of a suitable inhib-
itor, reﬂecting that the activity of ABC drug transporters can limit the
accumulation of substrates. In this approach, levels of the ﬂuorescent
substrate can be determined either on cellmonolayers following extrac-
tion (Sturmet al., 2001b), or byﬂow cytometry using cells in suspension
(Kobayashi et al., 2008).
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Fig. 4.Phylogenetic analysis of vertebrate ABCG2/Abcg2 transporters. Included in the analysis are transporter amino acid sequences from teleosts (Danio rerio,Gasterosteus aculeatus, Gadus
morhua, Oreochromis niloticus, Oryzias latipes, Takifugu rubripes, Tetraodon nigroviridis) and other vertebrates. For further details see the legend of Fig. 1.
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which the expression and activity of ABC drug transporters has been
ascertained include the kidneys, the liver, the intestine and the capillary
endothelia forming the blood–brain barrier (Fig. 6). Selectedmodel sub-
strates and inhibitors used in transport activitymeasurements in teleost
tissues are summarised in Table 1. Roles of ABC drug transporters in fur-
ther teleost tissues are likely to exist but require further investigation.
3.1. Kidney
In teleosts, the kidneys have central roles in the maintenance of the
internal electrolyte and acid–base balances (Marshall and Grosell,
2006) and in the excretion of metabolic waste products and chemicals
of endogenous or foreign origin (Kleinowet al., 2008). Glomerular ultra-
ﬁltration and tubular active secretion contribute to the renal excretion
of organic chemicals. Glomerular ﬁltration rates are greatly reduced in
euryhaline teleosts adapted to seawater, and somemarine teleosts pos-
sess nephrons lacking glomeruli (Beyenbach, 2004). Within the neph-
ron, the secretion of organic chemicals occurs mainly in the proximal
tubule, which is composed of cuboid epithelial cells rich in mitochon-
dria and possessing a dense layer of microvilli on their apical surfaces.
In a number of marine teleosts, nephrons consistmainly of proximal tu-
bules (~90% of nephron length), of which in vitro preparations can beobtained that allow the study of transport of ﬂuorescent model com-
pounds by confocal microscopy (Miller, 1987).
Historically, different transport systems have been functionally
characterised in the kidney tubule for “organic cations” (including
bases) and “organic anions” (including acids) (Wright and Dantzler,
2004), with both types of systems involving two transmembrane trans-
port steps, basolateral uptake and apical secretion. Members of the SLC
superfamily have important roles in these systems; however, these
transporters are beyond the scope of this article (for reviews, please
refer to El-Sheikh et al. (2008); Koepsell et al. (2007); Wright and
Dantzler (2004)). In addition, ABC transporters mediate the secretion
of bulkier organic ions into the renal tubule (Wright and Dantzler,
2004).
The transport of the organic base daunomycin (Mw 528 Da) into
proximal tubule lumen was inhibited by verapamil and cyclosporin A
in winter ﬂounder (Pleuronectes americanus) (Sussman-Turner and
Renfro, 1995) and killiﬁsh (Fundulus heteroclitus) (Miller, 1995), consis-
tent with a mechanism involving Abcb1 (Table 1). Immunostaining of
ﬂounder proximal tubule primary cultures with antibody C219 showed
a signal located to apical microvilli (Sussman-Turner and Renfro, 1995).
At pH 8.25, luminar daunomycin secretion in killiﬁsh proximal kidney
tubules was resistant to inhibition by tetraethylammonium (TEA; Mw
130), a “type I” organic cation (Mw b 400) and model substrate for
Fig. 5. Conserved synteny of the human (Homo sapiens) ABCG2 region to homologous regions in teleost genomes. Dotted lines illustrate that the human ABCG2 region is syntenic to green
spotted pufferﬁsh (Tetraodon nigroviridis) abcg2a and zebraﬁsh (Danio rerio) abcg2d.
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of themedia was decreased to 7.25, however, TEA caused a reduction in
cellular and luminal accumulation of daunomycin (Miller, 1995). This
ﬁnding indicated that at the lower pH “classical” organic cation trans-
port systems became involved in daunomycin transport in addition to
the Abcb1-like mechanism, which is in line with the higher proportion
of cationic daunomycin expected at pH 7.25 when compared to
pH 8.25 (Miller, 1995).
The secretion of the large organic anion ﬂuorescein-methotrexate
(Mw 923 Da) to killiﬁsh proximal tubular lumen was inhibited by
LTC4, cyclosporin A and verapamil, but remained unaffected by glutarate
and ouabain, and was largely sodium independent (Masereeuw et al.,
1996) (Table 1). Accordingly, basolateral uptake and luminal secretion
of ﬂuorescein-methotrexate were by mechanisms distinct from the
ouabain-sensitive, sodium-dependent “classical” transport system in-
volving exchange for dicarboxylates that had previously been described
for small organic anions such as ﬂuorescein (Mw 130 Da) (Masereeuw
et al., 1996). The inhibitory effects of LTC4 and cyclosporin A suggested
the luminar secretion of ﬂuorescein-methotrexate by a teleost homo-
logue of ABCC2 (Miller and Pritchard, 1997), an ABC drug transporter
known to show apical expression in the mammalian proximal tubule
(Table 1). Supporting this interpretation, the luminal membrane of kil-
liﬁsh proximal tubule showed immunoreactivity against an antibody1
2
4
Fig. 6. Expression and activity of ABC drug transporters in teleost tissues. Currently available d
(2) excretion of organic chemicals and limit the uptake of food-borne chemicals in the gut (3
brain barrier contribute to the low penetration of foreign chemicals into the brain (4). ABC d
epithelium and the blood–gonadal barriers; however, more research is required to substantiatraised against rabbit ABCC2 (Masereeuw et al., 2000). Examination of
the transport of other organic ions suggested the presence of different
transport systems in killiﬁsh tubules. In addition to activity with
the “classical” transport system, transport by an ABCC2-like
efﬂux mechanism could be demonstrated for sulforhodamine 101
(Mw 606 Da) (Masereeuw et al., 1996) and lucifer yellow (Mw 444 Da)
(Masereeuw et al., 1999) (Table 1). In addition, the presence of a putative
teleost ABCC4 homologue in killiﬁsh kidney was suggested by the
cellular-to-luminar transport of a ﬂuorescent cAMP analogue, which
was inhibited by the general MRP inhibitors MK571 and LTC4 and the
ABCC4-speciﬁc compounds cAMP and adefovir (Reichel et al., 2007)
(Table 1).
The teleost proximal tubule system was subsequently applied
to identify classes of renal drug efﬂux transporters interacting with
selected pharmaceuticals by studying custom-made ﬂuorescent ana-
logues of the relevant drugs. ABCB1-like transport was demonstrated
for ﬂuorescent derivatives of the anthelminth ivermectin and the
immunosuppressants cyclosporin A and rapamycin (Schramm et al.,
1995;Miller et al., 1997; Fricker et al., 1999) (Table 1). The HIV protease
inhibitors ritonavir and saquinavir inhibited ABCB1- and ABCC2-like
transport in killiﬁsh kidney tubules, and experiments with a ﬂuorescent
analogue of saquinavir further suggested that this compound is
transported by both transporters (Gutmann et al., 1999). Using a3
ata support the view that ABC drug transporters are involved in the renal (1) and biliary
). Moreover, ABC drug transporters in the endothelial capillaries constituting the blood–
rug transporters could potentially have roles in further teleost tissues including the gill
e or refute such roles.
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ABCB1- and ABCC2-like transport of the compound could be measured
in killiﬁsh kidney tubules (Gutmann et al., 2000).
3.2. Liver
The teleost liver has major roles in the homeostasis of amino acids,
carbohydrates and fatty acids. Moreover, numerous proteins are syn-
thesised in the liver and secreted into blood, for instance albumin-like
proteins, ﬁbronectins and vitellogenin (Hinton et al., 2008). In addition,
the liver plays a key role in the detoxiﬁcation of endogenous and foreign
compounds, including many organic chemicals having relevance as en-
vironmental pollutants (Schlenk et al., 2008). Hepatocytes are in contact
with blood perfusing the hepatic parenchyma at their sinusoidal
(basolateral) membranes, at which blood-borne chemicals can be
taken up. In the hepatocyte, chemicals may undergo phase I and II bio-
transformation metabolism (Schlenk et al., 2008). At the same time,
chemicals or their metabolites may be subject to efﬂux transport by
canalicular ABC pumps, resulting in biliary excretion. The importance
of the biliary route of excretion is illustrated by the large range of com-
pounds found in ﬁsh bile, which includes industrial chemicals such as
chlorophenols (Oikari and Kunnamo-Ojala, 1987), combustion products
such as polycyclic aromatic hydrocarbons (Collier and Varanasi, 1991)
and agricultural compounds such as pesticides (Lech et al., 1973;
Bradbury et al., 1986). Alternatively, chemicals or their metabolites
can leave the hepatocyte by being transported back into the blood by
sinosoidal ABC transporters, after which they may be subject to renal
excretion.
In mammals, the hepatic ABC drug transporters ABCB1, ABCC2 and
ABCG2 localise to the canalicular membrane, while ABCC1 and 3 are
expressed in the sinusoidal membrane (Chan, 2004). Other canalicular
ABC transporters mediate the secretion of bile acids (ABCB11), phos-
pholipids (ABCB4) and cholesterol (ABCG5/ABCG8) into the bile ﬂuid
(Hazard and Patel, 2007; Oude Elferink and Paulusma, 2007; Stieger
et al., 2007). Although not drug transporters, these ABC proteins con-
tribute to maintaining bile ﬂow and thus facilitate chemical excretion,
and for this reason existing studies on these pumps in ﬁsh will be
considered in this section.
In immunohistochemical investigations of guppy (Poecilia reticulata)
tissues using antibodies raised against mammalian P-glycoprotein,
monoclonal antibodies C219 and JSB-1 speciﬁcally stained bile canalicu-
li (Hemmer et al., 1995). Subsequently, C219 has been widely used to
detect hepatic P-glycoprotein in teleosts, in which it stained canalicular
structures in immunohistochemical experiments, and detected protein
fractions of the expected molecular mass of P-glycoprotein of
~170 kDa in immunoblots (Hemmer et al., 1998; Cooper et al., 1999;
Albertus and Laine, 2001; Sturm et al., 2001b; Bard et al., 2002b).
However, as the epitope recognised by C219 (VQEALD/VQAALD) is
conserved in ABCB4 and ABCB11 (Georges et al., 1990), as well as in
Abcb11 from winter ﬂounder (Pleuronectes americanus) (Chan, 1992),
C219 can be expected to cross-react with ABC transporters other than
Abcb1. The bile salt export pump Abcb11 shows high mRNA expression
in teleost liver (Loncar et al., 2010), and could therefore contribute to
the hepatic signal detected by C219 in teleosts.
Data on the hepatic mRNA expression of ABC drug transporters are
available for a number of teleost and elasmobranch species. Tutundjian
et al. (2002) cloned a fragment of abcb1 in turbot (Scophthalmus
maximus) and demonstrated expression of its mRNA in brain, intestine,
kidney and liver by RT-PCR. A cDNA encoding an abcc2 homologue was
cloned in the elasmobranch little skate (Raja erinacea), and showed
high expression levels in kidney, intestine and liver, where it located to
the canalicular membrane (Cai et al., 2003). The group of Smital and
co-workers isolated cDNAs of abcb1 and abcc2 from rainbow trout liver
(Zaja et al., 2008b), and reported mRNA copy numbers per ng of total
liver RNA of 8.61 × 102 for abcb1, 1.29 × 103 for abcc2, 2.55 × 101 for
abcc3 and 2.78 × 102 for abcg2 (Loncar et al., 2010). Expression of
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(b5 copies/ng of total RNA) (Loncar et al., 2010). The hepatic mRNA
expression of abcb1, different abcc paralogs, and abcg2 has been con-
ﬁrmed in a number of further teleost species in the context of eco-
toxicological studies (Bresolin et al., 2005; Paetzold et al., 2009;
Zucchi et al., 2010; Costa et al., 2012; Diaz de Cerio et al., 2012),
which will be discussed in detail below.
The transport activity of hepatic ABC drug transporters in teleosts
has been investigated by assessing the effects of selective inhibitors on
the accumulation, efﬂux or transport of ﬂuorescent or radiolabelled
model substrates, employing experimental models including whole
animals, livers perfused in situ, primary cultures of isolated hepatocytes
and membrane vesicles. The waterborne exposure of common carp
(Cyprinus carpio) to 3 mM rhodamine B resulted in a time-dependent
accumulation of the dye in liver and bile ﬂuid over 3 hours (Smital
and Sauerborn, 2002). When rhodamine B was combined with the
ABCB1 inhibitors verapamil or cyclosporin A this resulted in elevated
hepatic and biliary dye accumulation compared to ﬁsh exposed to the
ﬂuorescent probe alone (Smital and Sauerborn, 2002). In channel cat-
ﬁsh (Ictalurus punctatus) in situ liver perfusions, transport of rhodamine
123 fromperfusate to bilewas signiﬁcantly decreased in the presence of
verapamil (Kleinow et al., 2004). Verapamil also inhibited perfusate-to-
bile transport of estradiol, which in turn competed with rhodamine 123
transport (Kleinow et al., 2004). Similarly, verapamil enhanced the ac-
cumulation of doxorubicin by killiﬁsh (Fundulus heteroclitus) hepato-
cytes (Albertus and Laine, 2001), and verapamil, cyclosporin A,
doxorubicin and vanadate increased the accumulation of rhodamine
123 by rainbow trout (Oncorhynchus mykiss) hepatocytes (Sturm
et al., 2001b) (Table 1). While the above ﬁndings were interpreted as
evidence for the presence of ABCB1-like transporters in the teleost
liver, a later study employing further inhibitors (Abcb1: reversin 205,
Abcc: MK571) demonstrated that both ABCB1- and ABCC-like trans-
porters are involved in the transport of rhodamine 123 in trout hepato-
cytes (Zaja et al., 2008b) (Table 1). Two further studies with trout
hepatocytes used the inhibitor tariquidar in combination with rhoda-
mine 123 or doxorubicin to measure transport activity attributed to
Abcb1 (Bains and Kennedy, 2005; Hildebrand et al., 2009). While the
ABCB1 inhibitor tariquidar does not inhibit ABCCs, it can interact with
ABCG2 (Robey et al., 2004). In the elasmobranch little skate, liver
membrane vesicles were used to investigate ABCC-like transport ac-
tivity (Rebbeor et al., 2000). The uptake of tritiated S-dinitrophenyl-
glutathione and glutathione showed an ATP-dependent component that
was inhibited by ABCC substrates and GSH (Rebbeor et al., 2000).
Relatively little is known on ﬁsh ABC transporters involved in the se-
cretion of bile constituents. Conjugated bile salts are found in the bile of
all vertebrates, but different vertebrate groups show distinct differences
regarding the subclass composition of bile salts present in bile ﬂuid
(Moschetta et al., 2005). The abcb11 gene, which encodes the hepatic
bile salt export pump (BSEP), was originally isolated in a teleost
(Chan, 1992; Childs et al., 1995; Gerloff et al., 1998), suggesting a con-
servation of abcb11 across the vertebrates. In the elasmobranch little
skate (Raja erinacea), an antiserum raised against rat ABCB11 reacted
with proteins of an apparent mass of 210 kDa in immunoblots and re-
sulted in the immunostaining of bile canaliculi (Ballatori et al., 2000).
Subsequently, little skate abcb11 was cloned and shown to transport
taurocholate upon transfection into Sf9 cells (Cai et al., 2001). In rain-
bow trout, abcb11 was highly expressed in liver (Loncar et al., 2010),
and BSEP-like activity was detectable in cultured hepatocytes (Zaja
et al., 2008b) (Table 1). Cholesterol is found in bile ﬂuid in different ver-
tebrate groups, however it can greatly vary in concentration (Moschetta
et al., 2005). While the locus encoding the mammalian hepatic choles-
terol transporters ABCG5 and ABCG8 is highly conserved between
mammals and teleosts (Hazard and Patel, 2007), no direct evidence is
available regarding the hepatic expression and functional activity of
Abcg5 and Abcg8 in ﬁsh. Phospholipids, which are absent from the
bile of elasmobranchs and reptiles, are lacking or show very lowconcentrations in the bile of teleosts (Goto et al., 2003), and are found
at widely variable levels in the bile of different mammalian species
(Oude Elferink et al., 2004; Moschetta et al., 2005). Apparently there is
no active translocation of phospholipids into teleost bile indicating the
absence of functional homologues to mammalian ABCB4 in teleosts.
On the basis of available genomic data, some studies have suggested
that teleosts lack an ABCB4 orthologue (Annilo et al., 2006; Moitra
et al., 2011; Liu et al., 2013), while others came to the conclusion that
teleosts possess an ABCB4 orthologue resembling mammalian ABCB1
in function (Fischer et al., 2013).
3.3. Intestine
The gastrointestinal tract of ﬁsh has multiple functions, which in-
clude digestion and nutrient absorption, osmoregulation and mainte-
nance of the acid–base balance, and barrier and immune functions
(Marshall and Grosell, 2006; Bakke et al., 2011; Cain and Swan, 2011).
As in other animals, the intestine is a potential site of uptake of chemical
compounds other than nutrients from food (Kleinow et al., 2008),
which include anthropogenic contaminants as well as toxic chemicals
fromnatural sources. As an adaptation limiting potential adverse effects
of food-borne toxicants, biochemical defence systems, including
biotransformation enyzmes and drug transporters, are expressed in
the intestinal epithelium (Chan, 2004; Schlenk et al., 2008). In mam-
mals, the intestine is amajor site of expression of ABCdrug transporters,
some of which limit the oral absorption of drugs that are transport sub-
strates (reviewed by Oostendorp et al., 2009). Relatively little is known
about the expression and activity of ABC transporters in the gastrointes-
tinal system of ﬁsh. The immunohistochemical staining of lumenal sur-
faces of the intestinal epithelium in guppy (Poecilia reticulata) suggested
the expression of ABCB1-like proteins in the teleost gut (Hemmer et al.,
1995). In channel catﬁsh (Ictalurus punctatus), reactivity with mAB
C219 in immunoblots was lower in the intestine than in the liver (Doi
et al., 2001), whereas immunohistochemistry revealed a more pro-
nounced expression of reactive protein(s) in the distal than the proxi-
mal regions of the gut (Kleinow et al., 2000). [3H] vinblastine uptake
of membrane vesicles prepared from catﬁsh intestinal mucosa was
stimulated by ATP and inhibited by verapamil, consistentwith the pres-
ence of an ABCB1-like transporter (Doi et al., 2001) (Table 1). Among
different rainbow trout (Oncorhynchus mykiss) ABC drug transporters,
abcb1, abcc2, abcc3 and abcg2 showedmajormRNAexpression in the in-
testine, whereas abcc1, abcc4 and abcc5 mRNAs were present at low
abundances (b15 copies per ng of total RNA) (Loncar et al., 2010). Of
these transporters, abcb1, abcc2, and abcg2 showed higher levels of
mRNA expression in the distal than the proximal intestine (Loncar
et al., 2010).
3.4. Blood–brain barrier and blood–cerebrospinal ﬂuid barrier
To ensure optimal functioning of the vertebrate central nervous sys-
tem (CNS), the chemical composition of its extracellular ﬂuids is under
tight physiological control and the movement of molecules between
blood and CNS is restrained at anatomical interfaces such as the
blood–brain barrier and the blood–cerebrospinal ﬂuid barrier (Redzic,
2011). The blood–brain barrier is comprised of the endothelia of the
brain capillaries and separates blood from brain interstitial ﬂuid (Cserr
and Bundgaard, 1984). Its function is to protect the brain from poten-
tially neurotoxic compounds and prevent its exposure to the physiolog-
ical ﬂuctuations in concentrations of plasma solutes while at the same
time allowing for the exchange of ions, nutrients, metabolicwaste prod-
ucts and signalling molecules between blood and brain interstitial ﬂuid
(Redzic, 2011). The endothelial cells forming the blood–brain barrier
have low pinocytotic activity and possess tight junctions inter-
connecting adjacent cells, which foreclose the paracellular passage of
molecules (Ueno, 2009; Redzic, 2011). In consequence, the capillary
brain endothelium shows a high transendothelial electrical resistance
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epithelia (Crone and Christensen, 1981). Besides constituting an ana-
tomical barrier, brain endothelial cells actively mediate the transport
of ions, nutrients, neurotransmitters and metabolic waste products
across the endothelium through a multitude of transporters expressed
at the apical (blood side) and/or basolateral (brain side) cellmembranes
(Miller, 2010; Redzic, 2011). Inmammals, ABC drug transporters show-
ing an apical expression at the blood–brain barrier comprise ABCB1,
ABCC2, ABCC4, ABCC5 and ABCG2 (Ueno, 2009; Redzic, 2011). ABCC1
is present in brain endothelial cells but its subcellular localisation is
still a matter of debate (Dallas et al., 2006; Redzic, 2011).
Early studies have characterised the teleost blood–brain barrier as
tight based on its impermeability for dyes, inulin, iodine and horserad-
ish peroxidase (HRP); however, conﬂicting results suggesting a less
restrictive barrier function were obtained with epinephrine and thiocy-
anate (Cserr and Bundgaard, 1984). Recent studies conﬁrmed the
presence of a fully functional blood–brain barrier in zebraﬁsh using
HRP, a biotinylation agent and an ectopically expressed recombinant
protein as markers and demonstrated the presence of claudin-5 and
other tight-junction proteins in the microvessels (Jeong et al., 2008;
Xie et al., 2010). A role of ABC transporters in the teleost blood–brain
barrier is suggested by the observation that inhibitors of ABC drug
transporters increase the retention of rhodamine 123 in the zebraﬁsh
brain (Park et al., 2012).
The high therapeutic margin of the anti-parasitic drug ivermectin in
mammals is partly explained by its selectivity for ecdysozoan GABA-
and glutamate-gated ion channels (Lynagh and Lynch, 2012), and partly
due to the fact that ABCB1 activity in the brain capillary endothelia
limits the brain penetration of ivermectin, preventing interaction with
related vertebrate ion channels expressed in the central nervous system
(Schinkel et al., 1994). Relatively high brain levels of ivermectin were
measured in teleost ﬁsh following parenteral administration (Høy et al.,
1990; Katharios et al., 2004). While this suggests a limited efﬁcacy of
the teleost blood–brain barrier towards ivermectin, co-administration of
ivermectin with the ABCB1 inhibitor cyclosporin A resulted in increased
adverse behavioural effects compared to a treatment with ivermectin
alone (Bard andGadbois, 2007), suggesting that ABC pumps of the teleost
blood–brain barrier provide a partial protection against ivermectin
neurotoxicity.
Further evidence for roles of ABC transporters in the teleost blood–
brain barrier is provided by in vitro studies. Isolated killiﬁsh brain capil-
laries accumulated ABC transporter substrates from incubation media
and secreted the compounds into the capillary lumen in a concentrative
fashion (Miller et al., 2002). The transport of ﬂuorescent derivatives of
cyclosporin A and verapamil was inhibited by PSC-833 but not LTC4,
which is consistent with an Abcb1-dependent luminal transport mech-
anism (Miller et al., 2002) (Table 1). In contrast, luminal accumulation
of ﬂuorescein-methotrexate and sulforhodamine 101 was inhibited by
LTC4 but not PSC-833, suggesting the involvement of Abcc transporters
(Miller et al., 2002) (Table 1). Similar luminal accumulation of ﬂuores-
cent derivatives of cyclosporin A, verapamil and methotrexate was
demonstrated in isolated brain capillaries of spiny dogﬁsh shark
(Squalus acanthias) (Miller et al., 2002). Immunostaining using mAB
C219 and an antibody directed against rabbit ABCC2 localised ABCB1-
like and ABCC2-like proteins to the luminal surface of killiﬁsh brain cap-
illaries (Miller et al., 2002). In accordance with suggested roles in the
blood–brain barrier, ABC transporters showing transcript expression
in the rainbow trout brain were, in the order of decreasing abundance
expressed as copy numbers per ng of total RNA, abcb1 (1.38 × 103/ng),
abcc2 (1.38 × 102/ng), abcg2 (1.02 × 102/ng), abcc3 (8.4 × 10/ng),
abcc5 (2.65/ng), abcc4 (1.68/ng) and abcc1 (0.72/ng) (Loncar et al.,
2010).
Themain function of the choroid plexus (CP) epithelium is the secre-
tion of cerebrospinal ﬂuid (Cserr and Bundgaard, 1984). It consists of
mitochondria-rich cuboid cells that are interconnected by tight junc-
tions and possessmicrovilli on their apical sides facing the cerebrospinalﬂuid. The endothelial cells of the capillary network underlying the CP
epithelium on the basolateral side are fenestrated, so that the CP epithe-
lium constitutes the site of the blood–cerebrospinal ﬂuid barrier (Cserr
and Bundgaard, 1984; Redzic, 2011). TEER estimates obtained on bull-
frog CP explants mounted in Ussing chambers were in the range of
150 W cm2, which is similar to values obtained in leaky epithelia
(Saito and Wright, 1984). In mammals, ABC transporters expressed in
the CP epithelium include ABCC1 and ABCC4, which adopt a basolateral
localisation, ABCB1 and ABCG2, which are expressed apically, and
ABCC5, the localisation of which remains to be elucidated (Redzic,
2011). While ABCC1 is the most abundant of ABC transporter in the CP
epithelial cells, ABCB1 levels in the CP epithelium are low (Redzic,
2011).
No studies on the function of the CP exist in teleosts. However, the
CP epithelium in the elasmobranch spiny dogﬁsh shark (Squalus
acanthias) is anatomically easily accessible and explants of the CP in
this species have been used for in vitro transport studies using confocal
microscopy (Baehr et al., 2006; Reichel et al., 2008). Fluorescein-
methotrexate and sulforhodamine 101 were accumulated by CP cells
from incubationmedia, provided at the cerebrospinal ﬂuid side, and ac-
tively secreted into the subepithelial/vascular space (Baehr et al., 2006;
Reichel et al., 2008). Both cellular accumulation and vascular secretion
of the dyes were sensitive to inhibition by the ABCC inhibitors MK571
and LTC4 (Baehr et al., 2006; Reichel et al., 2008).3.5. Other tissues
In teleosts, the gill is amain site of gas exchange, osmoregulation and
excretion of nitrogenous waste products (Evans et al., 2005). Due to the
large surface of the gill epithelium, as well as the effective respiratory
ventilation of water and circulation of blood, the gills represent a dom-
inant site both for the absorption and the elimination of xenobiotics
(Kleinow et al., 2008). Relatively little is known about the expression
of ABC drug transporters in the ﬁsh gill. A study in guppy using mAB
C219, directed against mammalian ABCB1 but also known to crossreact
with other ABC transporters, reported a strong staining reaction in gill
chondrocytes and an absence of signal in ﬁlaments and lamellae
(Hemmer et al., 1995). In contrast, in gill tissue from killiﬁsh (Fundulus
heteroclitus) or high cockscomb blenny (Anoplarchus purpurescens) no
immunoreactive bands were visible in Western blots with C219 (Bard
et al., 2002a,b). In a study with rainbow trout, ABC drug transporters
showing major mRNA expression in gills were abcc2 and abcc3 when
data were reported as copy numbers per mass unit of total RNA, where-
asmRNAs encoding Abcc3, Abcg2 and to a lesser extent also Abcc5were
the most abundant ABC transcripts based on quantiﬁcation relative to
the reference gene ef1a (Loncar et al., 2010). No data are available on
the activity of ABC transporters in the ﬁsh gill.
The rectal gland is a NaCl-secreting organ of marine elasmobranchs
(Marshall and Grosell, 2006). In isolated rectal gland tubules from dog-
ﬁsh shark (Squalus acanthias), sulforhodamine 101 was taken up from
incubation medium and secreted into tubule lumen, suggesting addi-
tional roles of the rectal gland in xenobiotic excretion (Miller et al.,
1998a). Luminal secretion of sulforhodamine 101 in shark rectal gland
tubules was saturable, concentrative and sensitive to inhibition by
cyclosporin A and LTC4, but not verapamil, p-aminohippurate or TEA,
suggesting an involvement of Abcc pumps in the transport mechanism
(Miller et al., 1998a).
Inmammals, a number of ABC drug transporters are expressed in the
blood–testis barrier and in the placenta (Leslie et al., 2005). Little is
known about blood–gonadal tissue barriers in ﬁsh. A number of studies
have found marked mRNA expression of ABC transporters in gonads of
ﬁsh, which could be related to roles of the pumps in blood–tissue bar-
riers. In rainbow trout, transcripts of abcb1, abcc2–4 and abcg2 were
abundant in the ovaries (Loncar et al., 2010), whereas in zebraﬁsh
abcc1 mRNA showed a marked expression in both male and female
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2011a,b).
Evidence for the presence and activity of ABC drug transporters in
the teleost epidermis was provided in investigations using a rainbow
trout skin primary culture system (Shúilleabháin et al., 2005). In
epidermal cell cultures, the efﬂux of rhodamine 123 was inhibited by
verapamil. Moreover, a fraction of the cells in epidermal primary
cultures displayed positive immunoreactivity with the mAB C219
(Shúilleabháin et al., 2005). Exposure of cultured trout epidermal cells
to sediment elutriates from a polluted ﬁeld site resulted in an increase
of the number of intensely JSB1 positive cells and enhanced rhodamine
123 efﬂux activity (Shúilleabháin et al., 2005).
Mammalian stem cells show an increased expression and activity of
ABC efﬂux transporters, which are used as markers of stem cell identiﬁ-
cation (Bunting, 2002). Side population cells from the hematopoietic
tissue of zebraﬁsh kidney were characterised by an increased Hoechst
33342 dye efﬂux activity and showed marked abcg2a expression
(Kobayashi et al., 2008). Moreover, zebraﬁsh kidney side population
cells were enriched in hematopoietic stem cells (Kobayashi et al., 2008).
3.6. Fish embryos
Most teleosts are oviparous, with the complete embryonic develop-
ment taking place outside the maternal organism. The developing
“orphan” embryo thus is directly exposed to potentially adverse envi-
ronmental conditions that could affect development and it is a common
perception that this ontogenetic life phase is therefore particularly sen-
sitive (McKim, 1985; Oberemm, 2000). Correlations of toxicity data for
ﬁsh embryo and adult ﬁsh for various chemicals, however, show that
sensitivities of the different life stages are generally highly comparable
(Belanger et al., 2013), contradicting the notion of increased vulnerabil-
ity of teleost embryos to environmental stressors as compared to adult
stages. Indeed, despite the lack of differentiated organs “orphan”
embryos across aquatic animal taxa employ various cellular defence
mechanisms enabling them to dealwith a range of stressors in develop-
ment including changes in temperature, hypoxia, pathogens, UV radia-
tion, free radicals, and toxicants (Hamdoun and Epel, 2007). One
important component of the suite of defensive mechanisms are MDR
transporters (Hamdoun and Epel, 2007), which are also expressed and
active in teleost embryos. It was recently shown that the P-
glycoprotein Abcb4 acts as protective barrier against the uptake of
toxic compounds dissolved in the water by the zebraﬁsh embryo
(Fischer et al., 2013). Fish embryos where expression of functional
Abcb4 was disrupted by morpholino knockdown or by co-exposure to
ABC transporter inhibitors, such as cyclosporin A or PSC-833, showed
increased uptake of ﬂuorescent ABC transporter substrates rhodamine
B and calcein-AM (Table 1) and their sensitivity to the toxic impact of
the ABC transporter substrate vinblastine was increased (Fischer et al.,
2013). By efﬂuxing incoming chemicals Abcb4 keeps cellular levels of
those compounds in embryo tissues and cells low and forms a
multidrug-resistance type environment–tissue barrier, in analogy to en-
dogenous blood–tissue barriers. Abcb4 transcripts are found in the early
embryo before de novo transcription starts, which indicates that they
are maternally transferred to the embryo, and efﬂux activity can be ob-
served already in the very early embryo one hour after fertilisation
(Fischer et al., 2013). Similarly, transcripts of the MRPs abcc1 (Long
et al., 2011a) and abcc5 (Long et al., 2011b) are maternally transferred
to the zebraﬁsh egg, whereas transcripts of abcc2 occur not before 72 h
postfertilisation, indicating that this transporter has no relevant function
in the early embryo (Long et al., 2011d). The authors related a function of
all three transporters Abcc1, Abcc2 and Abcc5 with heavy metal detoxi-
ﬁcation in zebraﬁsh embryos and larvae (Long et al., 2011a,c,d), thus as-
sociating them to the suite of molecular detoxiﬁcation systems in
zebraﬁsh early life stages. Constitutive transcript expression levels of
ABC transporters were also determined in early life stages of Nile tilapia
(Oreochromis niloticus). As in zebraﬁsh, transcripts of P-glycoproteinabcb1b and of abcc1 were found in early developmental stages directly
after fertilisation of the egg, whereas abcc2, together with abcg2a and
abcb11, occurred in later stages (from pharyngula stage on) (Costa
et al., 2012). The function of Abcb11 as bile salt export pump (BESP) in
liver has been shown to be highly conserved across vertebrate taxa
(Ballatori et al., 2000; Cai et al., 2001) and accordingly high abcb11 tran-
script levels were found in teleost liver (Loncar et al., 2010); the
occurence of abcb11 transcripts in teleost embryos (Costa et al., 2012)
may thus be associated with the appearance of the embryonic liver.
An interesting question regardswhether ABC transporters have spe-
ciﬁc functions in the developing embryo that are distinct from the func-
tion in adult tissues. Indeed, a function essential for development of the
zebraﬁsh embryowas found for Abcc6a. The exact function of themam-
malian orthologue ABCC6 is not clear, but null mutations of ABCC6 are
associated with the inherited disorder pseudoxanthoma elasticum
(PXE), which is characterised by dystrophic mineralisation and frag-
mentation of soft connective tissues (Pfendner et al., 2007). In zebraﬁsh
embryos, expression of abcc6a is located in the Kupffer’s vesicles and in
the tail buds; upon knockdown of functional Abcc6a protein expression
embryos at 1 day after fertilisation showed shortening of the body,
delay of the development of the head, decreased tail length, and curving
of the caudal part and older embryos developed severe heart edemaand
died at 8 days after fertilisation (Li et al., 2010). The Abcc6 knockdown
effect in zebraﬁsh embryos was rescued by co-injection of mouse
Abcc6 mRNA (Li et al., 2010), which indicates that zebraﬁsh Abcc6a
and mouse ABCC6 have similar functional properties, but probably
have different functional physiological roles. The knockdown of
the Abcb4 multidrug transporter and of Abcb5 did not result in visible
developmental effects (Fischer et al., 2013) providing no evidence for
developmental roles of these transporters.
4. Substrates and inhibitors of teleost ABC transporters
While chemicals have been classiﬁed as transport substrates or inhib-
itors of speciﬁc ABC drug transporters, these two categories are not mu-
tually exclusive, as many substrates inhibit the transport of other
compounds, while some compounds classiﬁed as inhibitors are them-
selves transported. Chemical interaction has been studied in consider-
able depth for the mammalian drug transporter ABCB1, and to a lesser
extent for other drug transporters. These research efforts have had two
main drivers. Firstly, in order to overcome ABC transporter-related
MDR of cancers (Gottesman et al., 2002), studies have searched to iden-
tify non-cytotoxic inhibitors of ABCB1 and other MDR pumps, which are
called reversal agents, resistance modiﬁers or chemosensitisers (Ford
and Hait, 1993; Choi, 2005). Secondly, ABCB1 and possibly other drug
transporters can limit oral drug absorption and drug penetration into
sanctuary sites of the body. In consequence, ABC drug transporters can
provide obstacles for drug delivery and be the basis for drug–drug inter-
actions, so that for drugs other than reversal agents chemical interaction
with ABC pumps is generally an undesired trait (Calcagno et al., 2007;
Szakács et al., 2008).
Mammalian ABC drug transporters accept a wide range of structur-
ally and functionally unrelated pharmaceuticals as transport substrates
and are inhibited by a similarly wide range of drugs (Ford and Hait,
1990; Ambudkar et al., 1999; Choi, 2005; Deeley et al., 2006;
Krishnamurthy and Schuetz, 2006; Calcagno et al., 2007). Interaction
of mammalian ABC drug transporters has further been demonstrated
for environmentally relevant compounds including surfactants and pes-
ticides (Siegsmund et al., 1994; Bain and LeBlanc, 1996; Lanning et al.,
1996; Bain et al., 1997; Loo and Clarke, 1998; Oosterhuis et al., 2008).
Substrates and inhibitors of ABC transporters can be identiﬁed
through vectorial transport studies in cell monolayer systems
supporting polarised expression of the ABC transporter of interest
(Kim et al., 1998; Polli et al., 1999). However, ﬁsh cell lines suitable for
this type of approach await being identiﬁed. Moreover, transport
studies using assay monolayer systems are labour intensive to
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constraining the usefulness of this methodology for chemical
screening.
Methodologies to identify chemicals interacting with ABC trans-
porters at comparatively high sample throughput include cytotoxic-
ity and/or dye accumulation assays in drug-resistant cell lines
overexpressing speciﬁc ABC drug transporters. Such resistant cell
lines can be generated by subjecting non-resistant cell lines to a
step-wise selection with increasing levels of cytostatic drugs
(Riordan and Ling, 1985) or by transfection of suitable cell lines
with the transporter in question (Ueda et al., 1987). Cell lines over-
expressing speciﬁc ABC drug transporters show a decreased cellular
accumulation and toxicity of substrates of the relevant pump.
Accordingly, transporter substrates can be identiﬁed in cytotoxicity
assays as compounds showing a decreased toxicity in the resistant
when compared to the parental cell line (Szakács et al., 2008). In
contrast, in dye accumulation assays with drug-resistant cell lines,
both substrates and inhibitors increase the cellular accumulation of
ﬂuorescent dyes that are substrates of the studied transporter
(Homolya et al., 1993; Holló et al., 1994).
Another approach to investigate chemical interaction with ABC
pumps at high sample throughput is based on the measurement of
transporter ATPase activity in cell membrane fractions obtained from
cell lines overexpressing speciﬁc transporters (Ambudkar et al., 1992;
Doige et al., 1992) or generated in recombinant baculovirus/insect cell
expression systems (Sarkadi et al., 1992; Germann, 1998). In these
experimental systems, ABCB1 (P-glycoprotein) shows basal ATPase
activity in the absence of added substrates of the transporter, which is
dependent on the presence of cholesterol in the cell membrane
(Garrigues et al., 2002). Chemicals interacting with ABCB1 typically
stimulate basal transporter ATPase activity in a concentration-
dependent way. For some compounds, ATPase activities follow a
biphasic concentration-effect proﬁle, in which increasing levels of the
compound provoke increasing ATPase activation up to an optimal
concentration beyond which inhibition occurs (Sarkadi et al., 1992;
Litman et al., 1997). Other chemicals cause inhibition of basal ABCB1
ATPase activity only, with no apparent stimulation at low levels
(Litman et al., 1997).
The study of chemical interactionwith ABC transporters by differ-
ent methodologies can at times lead to conﬂicting results, particular-
ly with systems in which transport is not measured directly (Szakács
et al., 2008). The transport of chemicals by ABC drug transporters is a
complex process inﬂuenced by various factors, including access and
afﬁnity to the transporter’s drug binding site(s) and the ability of
the compound to induce ATPase hydrolysis and concomitant confor-
mation changes of the protein effecting transmembrane transloca-
tion of the chemical. The recently achieved X-ray structure of
ABCB1 in the apo and drug-bound state (Aller et al., 2009) has
revealed that ABCB1 possesses a large internal cavity which accom-
modates distinct drug-binding sites and has portals allowing the
entry of substrates from both the cytoplasm and the inner leaﬂet of
the cell membrane. In addition to direct chemical interaction with
ABCB1, the chemical’s permeability for the cellular membrane is an
important factor in determining whether apparent transmembrane
transport will occur (Stein, 1997). Compounds effectively extruded
by ABC efﬂux pumps, such as the rhodamine 123 and doxorubicin,
typically show low to moderate rates of passive membrane perme-
ation (Eytan et al., 1996b; Von Richter et al., 2009). In contrast, rever-
sal agents that are not transported themselves, such as quinidine and
verapamil, typically show high membrane permeability (Eytan et al.,
1996b; Von Richter et al., 2009).
The following sections summarise studies providing evidence for the
interaction of chemicals with teleost ABC drug transporters based on
studies employing tissue, cellular and subcellularmodels. Subsequently,
the metabolic costs of chemical interaction with ABC transporters are
addressed.4.1. Results for primary cell culture systems
As reviewed in detail in Section 3, themeasurement of the activity of
ABC drug transporters in cell or tissue cultures involves the demonstra-
tion of effects of speciﬁc inhibitors on the accumulation or efﬂux of
model substrates. Model substrates and inhibitors include a number of
pharmaceuticals, such as the anthracyclins daunorubicin and doxorubi-
cin, the calcium channel blocker verapamil and the anti-retroviral drug
adefovir (Table 1). Studies with isolated kidney tubules have further
demonstrated the interaction of renal teleost Abcb1 and/or Abcc trans-
porterswith a range of drugs, including the immunosuppressants cyclo-
sporin A and rapamycin (Schramm et al., 1995; Miller et al., 1997), the
anthelmintic ivermectin (Fricker et al., 1999), the HIV protease inhibi-
tors ritonavir and saquinavir (Gutmann et al., 1999), and the somato-
statin analogue octreotide (see Section 3.1 for details). These data
suggest that teleost ABC drug transporters resemble their mammalian
counterparts in that they interact with a wide range of chemicals.
A few studies have used primary cell culture systems or organ perfu-
sions to investigate the interaction of teleost ABC transporters with en-
vironmentally relevant chemicals. The industrial chemical bisphenol A,
which is present in many plastics and the coating of food cans, exerted
differential effects on xenobiotic transport in killiﬁsh kidney tubules,
inhibiting ABCC-like luminal secretion of sulforhodamine but stimulat-
ing the efﬂux of mitoxantrone (Nickel et al., 2013). The fungicide
prochloraz and, less effectively, the xenoestrogen nonylphenol
ethoxylate inhibited efﬂux of rhodamine 123 from rainbow trout
hepatocytes (Sturm et al., 2001a). Similarly, the surfactant linear
alkylbenzene sulfonate decreased rhodamine 123 transport into bile
in perfused catﬁsh liver (Tan et al., 2010).
4.2. Results for cell lines
Step-wise selection of the topminnow (Poeciliopsis lucida) hepatoma
cell line PLHC-1 with increasing levels of doxorubicin was used to gen-
erate the subline PLHC-1/dox that shows a 45-fold reduction in doxoru-
bicin sensitivity compared to the parental cell line (Zaja et al., 2008a).
Using relative quantiﬁcation by RT-qPCR, abcb1 expression in PLHC-1/
dox compared to PLHC-1 was found to be 42-fold increased when
normalised to β-actin (Zaja et al., 2008a) and 160-fold increased when
normalised to 18S RNA (Zaja et al., 2011), with Abcb1 overexpression
in the selected cell line further being apparent from immunoblot analy-
ses (Zaja et al., 2008a). In addition, PLHC-1/dox cells showed small in-
creases (≤4.4-fold) in transcript levels of abcc1, abcc2, abcc4 and
abcc10,whereas abcg2mRNA levels were decreased (Zaja et al., 2011).
Compared to PLHC-1, cyctotoxicity in PLHC-1/dox cells was de-
creased not only for doxorubicin, but also for other cytostatic drugs
known to be substrates of human ABCB1, including the anthracyclines
daunorubicin, the Vinca alkaloids vinblastine and vincristine, and the
topoisomerase inhibitor etoposide (Zaja et al., 2008a) (Table 2). Howev-
er, the resistance spectrum of PLHC-1/dox did not extend to the MRP
substrates methotrexate and cisplatin (Zaja et al., 2008a) (Table 2). A
number of pharmaceuticals known to be substrates and/or inhibitors
of human ABCB1, including the calcium channel blockers verapamil,
nicardipine and diltiazem and the alkaloids quinidine, reserpine and
colchicine also interacted with P. lucida Abcb1, as indicated by positive
effects on dye accumulation in PLHC-1/dox cells (Zaja et al., 2011)
(Table 2). Dye accumulation in the Abcb1-overexpressing cell line was
further increased by model inhibitors (Table 2), of which cyclosporin
A, PSC-833 and reversin 205 are considered to be speciﬁc for ABCB1,
whereas MK571 and Ko143 are in mammalian systems selective for
MRPs and ABCG2, respectively (Zaja et al., 2011). Aswould be expected,
some of the model inhibitors further had activity as reversal agents ca-
pable of abrogating the doxorubicin resistance of PLHC-1/dox cells (Zaja
et al., 2008a) (Table 2).
PLHC-1/dox cells were further used to investigate the interaction of
environmental pollutants with P. lucida Abcb1. Environmental
Table 2
Interactions of chemicals with teleostean ABC efﬂux transporters. Different types of cytotoxicity assays, aswell asﬂuorescent dye accumulation and ATPase activity assays, have been used
to reveal chemical interaction with teleost ABC transporters. In these assays, chemicals can interact with ABC transporters as substrates (S) and/or inhibitors (I), or fail to show such in-
teraction (non-interacting compounds, N). Teleost transporters studied to date include Poeciliopsis lucidaAbcb1, which is overexpressed in the cell line PLHC-1/dox (Caminada et al., 2008;
Zaja et al., 2008a, 2011), andDanio rerioAbcb4,whichhas been expressed in baculovirus-transfected insect cells (Fischer et al., 2013). Compounds showing decreased cytotoxicity in PLHC-
1/dox as compared to the parental cell line PLHC-1 are putative transport substrates of P. lucida Abcb1, as are chemicals the cytotoxicity of which is potentiated by the ABCB1/Abcb1 in-
hibitor cyclosporin A. Chemicals reversing the doxorubicin resistance of PLHC-1/dox or enhancing the accumulation of the ﬂuorescent ABCB1/Abcb1 substrate calcein-AM are regarded
inhibitors of P. lucida Abcb1 transport activity. In ATPase assays, substrates have been deﬁned as chemicals stimulating ATPase activity, while inhibitors have been deﬁned as substances
decreasing basal ATPase activity in a studywith P. lucidaAbcb1 (Zaja et al., 2011) and as compounds decreasing verapamil-stimulated activities in a studywithD. rerioAbcb4 (Fischer et al.,
2013). Please see text for further explanations.
Poeciliopsis lucida Abcb1 Danio rerio Abcb4
Substance Cytotoxicity assays Calcein-AM assay ATPase assay1 ATPase assay2
Cytostatic drugs
Doxorubicin S3 N4 N I5
Daunorubicin S3 n.d. n.d. n.d.
Vinblastine S3 N4 N I, S5
Vincristine S3 n.d. n.d. I5, S5
Etoposide S3 N4 N n.d.
Mitoxantrone n.d. N4 I n.d.
5-Fluorouracil n.d. N4 I n.d.
Methotrexate N3 n.d. N n.d.
Cisplatin N3 n.d. N n.d.
Calcium channel blockers
Verapamil I6 I4 S S
Nicardipine n.d. I4 S n.d.
Diltiazem n.d. I4 S n.d.
Alkaloids
Quinidin n.d. I4 S n.d.
Reserpine n.d. I4 I n.d.
Colchicine S3 I4 S n.d.
Fluorescent model substrates
Rhodamine 123 n.d. n.d. S n.d.
Rhodamine B n.d. n.d. n.d. S5
Calcein-AM n.d. n.d. n.d. I, S
Hoechst 3334 n.d. I4 I n.d.
Model inhibitors
Cyclosporin A I6 I4 I I, S
PSC-833 I6 I4 I I, S
MK571 N6 I4 I I
Reversine 205 n.d. I4 S n.d.
Ko143 n.d. I4 N n.d.
Environmental pharmaceuticals
Pravastatin n.d. N4 S n.d.
Atorvastatin S7 I4 I n.d.
Sildenaﬁl I6 I4 S n.d.
Propranolol S7 I4 S n.d.
Tamoxifen I6 I4 S n.d.
Fenoﬁbrate I6 n.d. n.d. n.d.
Acebututolol S7 n.d. n.d. n.d.
Pesticides
Endosulfan n.d. I4 I n.d.
Diazinon n.d. I4 S n.d.
Fenoxycarb n.d. I4 N n.d.
Chlorpyrifos n.d. N4 S n.d.
Malathion n.d. I4 N n.d.
Fosalon n.d. I4 S n.d.
Dichlorodiphenyl-dichloroethylene n.d. I4 I n.d.
Polycyclic musks
Galaxolide n.d. n.d. n.d. I, S
Tonalide n.d. n.d. n.d. I5, S
Polycyclic aromatic hydrocarbons
Benzo[a]pyrene n.d. N4 N n.d.
Phenanthrene n.d. n.d. n.d. I, S5
Toxic metals
As2O3 n.d. N4 S n.d.
n.d.: not determined.
1 Inhibition effects were determined on basal ATPase activities (Zaja et al., 2011).
2 Inhibition effects were determined on verapamil-stimulated ATPase activities (Fischer et al., 2013).
3 S: The cytotoxicity in PLHC-1/dox was decreased as compared to that in PLHC-1; N: The cytotoxicity was similar in both cell lines (Zaja et al., 2008a).
4 Zaja et al. (2011).
5 Effects were statistically not signiﬁcant (Fischer et al., 2013).
6 I: The compound enhanced the cytotoxicity of doxorubicin in PLHC-1/dox; N: The compound had no effects on doxorubicin cytotoxicity (Caminada et al., 2008; Zaja et al., 2008a).
7 The cytotoxic effects of the compound were enhanced by the ABCB1/Abcb1 inhibitor cyclosporin A (Caminada et al., 2008).
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assays in PLHC-1/dox cells and/or acted as reversal agents (Caminada
et al., 2008) (Table 2). Another experimental approach to reveal chem-
ical interaction with P. lucida Abcb1 involved testing whether the toxic-
ity in PLHC-1/dox cells was enhanced by the co-treatment of cells with
the ABCB1 inhibitor cyclosporin A. Again, several environmental
pharmaceutics showed positive results, suggesting they represent sub-
strates of P. lucida Abcb1 (Caminada et al., 2008) (Table 2). Effects on
dye accumulation by PLHC-1/dox cells were further demonstrated for
a range of pesticides, suggesting they might be substrates and/or inhib-
itors of P. lucida Abcb1 (Zaja et al., 2011) (Table 2). Similarly, inhibitory
activity on Abcb1-related transport in PLHC-1/dox was demonstrated
for a range of waste water components (Smital et al., 2011).
In zebraﬁsh, cadmium selection of the ﬁbroblast-like cell line ZF4
was used to generate the cadmium-resistant line ZF4-Cd (Long et al.,
2011c). ZF4-Cd cells are cross-resistant to cadmium, mercury, arsenate
and arsenite and show an enhanced mRNA expression of abcc2, abcc4
and mt2 genes (Long et al., 2011c). Moreover, ZF4-Cd cells possess
elevated levels of glutathione (Long et al., 2011c).
A number of permanent ﬁsh cell lines have been shown to constitu-
tively express ABC transporters, suggesting it may be feasible to create
further cellular models overexpressing ABC pumps. Lines characterised
regarding their complement of ABC transporters include the SAE
Squalus acanthias shark embryo-derived cell line (Kobayashi et al.,
2007), seven rainbow trout cell lines (Fischer et al., 2011) and the top-
minnow (Poeciliopsis lucida) hepatoma cell line PLHC-1 (Zaja et al.,
2007). Relative mRNA levels of ABC transporters were similar among
rainbow trout cell lines RTL-W1, R1, RTH-149, RTgill-W1, RTG-2,
RTgutGC and RTbrain, with mRNA levels abcc1-3 and abcc5 exceeding
those of Abcb and Abcg subfamily drug transporters by 80- to over
1000-fold (Fischer et al., 2011).
4.3. Results with ATPase assays
In teleosts, ATPase assays have been performed with P. lucida Abcb1
andD. rerioAbcb4, respectively, testing a range of compounds that com-
prise known substrates and inhibitors of mammalian ABC transporters
and environmentally relevant chemicals (Table 2) (Zaja et al., 2011;
Fischer et al., 2013). Recently, ATPase assays were also used in effect di-
rected analysis to detect compounds interacting with P. lucida Abcb1 in
environmental samples (Zaja et al., 2013). For ATPase assays, cell mem-
branes enriched in P. lucida Abcb1 were prepared from the PLHC-1/dox
cell line overexpressing the transporter (Zaja et al., 2011), whereas
membrane fractions containing D. rerio Abcb4 were obtained following
baculovirus/insect cell expression (Fischer et al., 2013).
Chemicals that stimulated the ATPase activity of P. lucida Abcb1
were categorised as substrates of the transporter, while inhibitors of
the basal ATPase activity of P. lucidaAbcb1were classiﬁed as transporter
inhibitors (Zaja et al., 2011) (Table 2). In mammalian systems,
chemicals stimulating the ATPase activity of ABCB1 are known to com-
prise substances that are substrates in cellular transport assays as well
as compounds that are inhibitors of transport activity in cellular assays
(Sarkadi et al., 1992; Litman et al., 1997). Conversely, inhibitors of
ABCB1 ATPase typically constitute inhibitors of transport activity in cel-
lular assays (Litman et al., 1997; Von Richter et al., 2009). Taking this
into account, the results from P. lucidaAbcb1 ATPase assays are in accor-
dance with earlier ﬁndings from cytotoxicity and dye accumulation as-
says in PLHC-1/dox cells for many compounds, including calcium
channel blockers and alkaloids, as well as most of the model inhibitors,
pesticides and environmental pharmaceutics (Table 2).
However, diverging results between assays were observed for the
cytostatic drugs etoposide and doxorubicin, the latter of which was
used in generating the resistant PLHC-1/dox cell line (Table 2). The
lack of effects of these chemicals on Abcb1 ATPase activity (Table 2)
may seem surprising, considering that Abcb1 overexpression has been
suggested as the main molecular factor behind the resistance of PLHC-1/dox cells to these cytotoxic compounds, which implies their cellular
efﬂux by this transporter (Zaja et al., 2008a, 2011). However, only
small stimulating effects on the ATPase activity of human ABCB1 have
been reported for a number of conﬁrmed ABCB1 substrates, which in-
clude etoposide and doxorubicin (Polli et al., 2001). As ABCB1 displays
a high basal ATPase activity in the absence of added substrate, it has
been hypothesised that substrates stimulating ATPase activity only by
a small degree may go unnoticed due to the high basal ATPase activity
of ABCB1 (Eytan et al., 1996a).
Following expression of D. rerio Abcb4 in the baculovirus/insect cell
system, a range of chemicals were examined for effects on ATPase activ-
ity of the transporter (Fischer et al., 2013) (Table 2). The ABCB1 reversal
agent verapamil and the ABCB1 substrate rhodamine 123 stimulated
basal ATPase activity of D. rerio Abcb4, and were thus classiﬁed as
substrates of the transporter (Fischer et al., 2013) (Table 2). The
ABCB1 substrate doxorubicin and the ABCC/Abcc inhibitor MK571
inhibited verapamil-stimulated ATPase activities of D. rerio Abcb4 and
were therefore categorised as inhibitors of the transporter (Fischer
et al., 2013) (Table 2). The remaining compounds tested qualiﬁed both
as substrates and inhibitors according to the above criteria and included
the Vinca alkaloids vinblastine and vincristine, the model compounds
calcein-AM, cyclosporin A and PSC-833, and the environmental pollut-
ants phenanthrene, galaxolide and tonalide (Table 2) (Fischer et al.,
2013). (Table 2).
The teleostean Abcb1 and Abcb4 proteins and human ABCB1 appear
to be largely corresponding with regard to function and substrate
spectra, but ATPase assays reveal subtle differences among transporter
speciﬁcities. While the ABCB1 reversal agent cyclosporin A inhibits
ATPase activity of ABCB1 (Von Richter et al., 2009) and P. lucida Abcb1
(Table 2) (Zaja et al., 2011), it provoked a marked stimulation of
D. rerio Abcb4 ATPase activity (Table 2) (Fischer et al., 2013). Further-
more, the ABCB1 substrate vinblastine stimulated ATPase activities of
human ABCB1 (Sarkadi et al., 1992) and D. rerio Abcb4 (Fischer et al.,
2013) but had no effects on P. lucida Abcb1 ATPase activity (Zaja et al.,
2011) (Table 2).
4.4. Metabolic costs of chemical interaction with ABC transporters
ABC transportersmediate the translocation of their substrates across
membranes by an ATP-dependent mechanism. The energetic costs of
transport of rhodamine 123 and doxorubicin were estimated in two
studies with isolated cultured rainbow trout hepatocytes (Bains and
Kennedy, 2005; Hildebrand et al., 2009). Exposure of hepatocytes to 5
and 10 mM rhodamine 123 increased respiration by 18.5% and 25.7%
over basal rates, respectively (Bains and Kennedy, 2005). The altered
respiration rates were not due to direct effects of rhodamine 123 onmi-
tochondria. Co-treatment of hepatocytes with the ABCB1 inhibitor
tariquidar inhibited the cellular efﬂux of rhodamine 123 and caused
respiration rates to return to basal levels (Bains and Kennedy, 2005).
When doxorubicin-treated hepatocytes were allowed to efﬂux
the anthracycline for 3 h, this resulted in an up to 25% decrease of cellu-
lar ATP levels compared to parallel incubations of untreated cells
(Hildebrand et al., 2009). In contrast, following the incubation of
doxorubicin-treated hepatocytes in the presence of tariquidar, a
decreased efﬂux of doxorubicin was observed and cellular ATP levels
remained unchanged (Hildebrand et al., 2009). While these data
suggest that ABC drug transporter activity is associated with signiﬁcant
energy costs, exposure of rainbow trout to restricted feeding intake or
fasting for up to 9 weeks did not result in signiﬁcant changes in hepatic
rates of rhodamine 123 transport (Gourley and Kennedy, 2009).
5. Regulation of expression of teleost ABC drug transporters
Genomic andnon-genomicmechanisms contribute to the regulation
of ABC transporter activity in different tissues. Genomic mechanisms of
regulation include genetic and epi-genetic effects, the modulation of
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by miRNAs (Masereeuw and Russel, 2012). Mechanisms of non-
genomic regulation comprise the insertion of transporters into and
their retrieval from the cell membrane, as well as posttranslational
modiﬁcations such as phosphorylation and glycosylation and protein–
protein interactions (Masereeuw and Russel, 2012). Comprehensive re-
views are available on the regulation of mammalian ABC transporters in
tumour cells (Scotto, 2003; Chen and Sikic, 2012; Chen et al., 2012) and
in normal tissues including liver (Kipp and Arias, 2002; Chan, 2004;
Roma, 2008), intestine (Estudante et al., 2013), kidney (Masereeuw
and Russel, 2012), testis (Mruk et al., 2011) and brain (Miller, 2010;
Chan et al., 2013).
5.1. Regulation of ABC transporters in cancer cells
MDR in cancer often is based on the enhanced expression of ABCB1
and other ABC drug transporters in tumour cells (Gottesman et al.,
2002). A number of genetic and epi-genetic changes commonly ob-
served in MDR tumour cells are believed to contribute to enhanced
ABC drug transporter expression (reviewed by Chen and Sikic, 2012).
Genetic changes include gene rearrangements leading to a juxtaposition
of other active promoters to the ABCB1 promoter, thus effecting its de-
repression (Chen and Sikic, 2012). Moreover, enhanced expression of
ABCB1 following cancerous cellular transformation has been found to
be linked to mutations in oncogenes and tumour suppressor genes
such as p53 (Chen and Sikic, 2012). Among epi-genetic changes affect-
ing ABC drug transporter expression in cancers, de-methylation and
complex changes in acetylation status have been suggested to contrib-
ute to the de-repression of the ABCB1 promoter (Chen and Sikic, 2012).
In a number of marine and freshwater ﬁsh, an increased incidence of
different hepatic lesions including neoplasms has been reported from
polluted habitats (Black and Baumann, 1991; Myers et al., 1991;
Vethaak and Jol, 1996; Vethaak and Wester, 1996). Epidemiological
analyses of available data strongly support a role of environmental
contaminants, particularly PAHs, in the aetiology of these pathologies
(Rotchell et al., 2008). Biochemical changes associated with hepatocel-
lular carcinogenesis have been studied in European ﬂounder
(Platichthys ﬂesus) from polluted sites (Köhler et al., 1998; Koehler
et al., 2004). Compared to healthy liver tissue, preneoplastic basophilic
foci, as well as hepatic adenomas and carcinomas showed an increase
in immunoreactivity with mAB C219, which was interpreted as an up-
regulation of Abcb1 (Koehler et al., 2004). In contrast, C219 reactivity
was unchanged in early eosinophilic preneoplastic foci (Koehler et al.,
2004). Similarly, in killiﬁsh from a creosote-contaminated environment
the immunochemical C219 signal was increased in hepatocellular carci-
nomas, but not in early proliferative hepatic lesions (Cooper et al.,
1999). In addition, ﬂounder hepatocellular carcinomas showed an in-
crease in glucose-6-phosphate dehydrogenase activity and glutathion-
S-transferase (GST)-A expression, and a decrease in CYP1A1 levels
compared to healthy hepatic tissue (Koehler et al., 2004). Differences
in gene expression between normal liver tissue and hepatic adenomas
and carcinomas were investigated using microarray technology in
dab (Limanda limanda) (Small et al., 2010). Fifty genes that best
characterised the tumour type and sex of the host included CYP1A and
other biotransformation enzymes, but no ABC transporters (Small
et al., 2010). Compared to hepatic tissue from non-cancer bearing dab,
there was a signiﬁcant decrease in global DNA methylation in hepato-
cellular carcinomas and surrounding non-cancerous liver tissue
(Mirbahai et al., 2011).
5.2. Regulation of ABC transporters as part of a general cellular stress
response
In mammalian tissues, the expression of ABCB1 can be upregulated
in response to cellular stress signals including heat shock, injury, inﬂam-
mation, hypoxia, and UV and X radiation exposure (Scotto, 2003). Theeffects of heat shock on renal drug transport were studied in primary
cultures ofwinter ﬂounder (Pleuronectes americanus) renal proximal tu-
bule cells (Sussman-Turner and Renfro, 1995). As reviewed above,
peritubular to luminal daunorubicin transport in this system involved
Abcb1-like transporters. Mild heat shock (5 °C elevation for 6–8 h
followed by incubation at normal temperature) stimulated
transepithelial transport of the ABCB1 substrate daunorubicin, with ef-
fects being protein synthesis dependent (Sussman-Turner and Renfro,
1995).
5.3. Roles of transcription factors in the regulation of ABC transporters by
chemicals
Different nuclear receptors are involved in the transcriptional regu-
lation of mammalian ABC drug transporters by endogenous and foreign
chemicals (Chen et al., 2012). The pregnane xenobiotic receptor (PXR)
was isolated for its role as a factor mediating the chemical regulation
of isozymes of the CYP3A subfamily (Bertilsson et al., 1998; Blumberg
et al., 1998; Kliewer et al., 1998). PXR is further involved in the regula-
tion of other biotransformation enzymes (Blumberg et al., 1998; Xie
et al., 2003) as well as ABC transporters including ABCB1 and ABCC2
(Dussault et al., 2001; Geick et al., 2001; Synold et al., 2001; Kast et al.,
2002). While ligands of PXR comprise steroid hormones, bile acids
and a wide range of organic chemicals, pronounced species differences
in ligand selectivity exist (Jones et al., 2000; Ekins et al., 2008). The con-
stitutive androstane receptor (CAR) shows sequence homology to PXR
and overlaps with PXR in ligand spectrum and range of target genes
(Waxman, 1999; Moore et al., 2000; Maglich et al., 2002). Teleosts pos-
sess one receptor showing sequence homology to both PXR and CAR
(Maglich, 2003; Handschin et al., 2004), which has been named PXR be-
cause functionally it resembles PXR rather than CAR (Moore et al.,
2002). The zebraﬁsh PXR has a more restrained ligand spectrum than
its mammalian counterparts, accepting only a subset of xenobiotic and
steroid agonists of mammalian PXRs (Moore et al., 2002; Ekins et al.,
2008; Fidler et al., 2012). Among different bile salts tested, only the
main zebraﬁsh bile salt cyprinol sulphate activated zebraﬁsh PXR
(Moore et al., 2002; Krasowski et al., 2005). In contrast, in green spotted
puffer, which shows a more diverse physiological bile salt proﬁle, a va-
riety of bile salts were agonists of PXR (Krasowski et al., 2011). In
zebraﬁsh hepatocyte cultures, PXR activators induced enzyme activities
that are in mammals speciﬁc for CYP3As and CYP2Cs (Reschly et al.,
2007). Moreover, cyprinol sulphate treatment increased the abundance
of hepatic abcb5 transcripts (Reschly et al., 2007). In another study,
treatment of zebraﬁsh with the PXR ligand pregnenolone 16α-
carbonitrile provoked increases (1.6- to 1.9-fold) in the mRNAs levels
of PXR, abcb1 (now called abcb4) and CYP3A (Bresolin et al., 2005).
The insecticide chlorpyrifos is a known PXR ligand in zebraﬁsh and
human (Ekins et al., 2008). Exposure of killiﬁsh to the metabolically ac-
tivated oxon form of chlorpyrifos induced hepatic immunoreactivity to
the Abcb1 mAB C218 (Albertus and Laine, 2001). Taken together, the
above data suggest that teleost PXRs are involved in the regulation of
detoxiﬁcation pathways, which seems to include roles in the chemical
induction of certain ABC transporters.
The aryl hydrocarbon receptor (AhR) is a ligand-dependent transcrip-
tion factor of the bHLH-PAS (basic Helix-Loop-Helix Per-ARNT-Sim) fam-
ily of transcriptional regulators (Hahn, 1998). AhR binds a broad
spectrum of planar aromatic organic chemicals and acts as a key tran-
scriptional regulator of a battery of genes that in mammals include the
important phase I biotransformation enzymes CYP1A1 and CYP1A2, as
well as phase II enzymes (Nebert et al., 2000). Early studies in rodents
have demonstrated induction of hepatic ABCB1 by carcinogens that
are known AhR agonists, such as 2,3,7,8-tetrachlorodibenzodioxin, 2-
acetylaminoﬂuorene and 3-methylcholanthrene (Burt and Thorgeirsson,
1988; Gant et al., 1991; Fardel et al., 1996). However, subsequent investi-
gations revealed that the mechanism of ABCB1 induction by these com-
pounds does not involve the AhR (Teeter et al., 1991; Deng et al., 2001).
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based on results obtained in the human colon adenocarcinoma cell line
Caco-2 (Ebert et al., 2005).
In teleost ﬁsh, experimental exposures to AhR agonists had variable
effects on the expression of ABC drug transporters. In killiﬁsh, injection
with 3-methylcholanthrene provoked the expected induction of CYP1A
in liver, but had no effects on hepatic levels of ABCB1-like proteins,
determined in immunoblots with mABC C219 (Cooper et al., 1999;
Bard et al., 2002a). Similarly, injection of cockscomb blennies with
β-naphtoﬂavone did not alter hepatic expression of ABCB1-like pro-
teins (Bard et al., 2002b). The dietary treatment of catﬁsh with AhR
agonists (b-naphtoﬂavone, 3,4,3′,4′-tetrachlorobiphenol and benzo
[a]pyrene) failed to cause signiﬁcant expression changes of ABCB1-
like proteins in the intestinal mucosa, measured using mAB C219
(Doi et al., 2001). In another study, a signiﬁcant increase in C219 im-
munostaining in themucosa of the distal intestine was observed in cat-
ﬁsh treated orally with vinblastine or b-naphthoﬂavone (Kleinow et al.,
2000). Subchronic (14 days) waterborne exposure of Nile tilapia
(Oreochromis niloticus) to the AhR agonist benzo[a]pyrene increased
the mRNA levels of abcc2 in gills and of abcg2 in liver and proximal in-
testine, but had no effects on abcb1 and abcc1 transcript abundance
(Costa et al., 2012).
Peroxisomeproliferator-activated receptors (PPARs) bind fatty acids
and theirmetabolites andparticipate in the regulation of genes involved
in energy metabolism (Feige et al., 2006). A role of PPARa in regulating
ABCB4 expression has been demonstrated in mice (Kok et al., 2003),
while the regulation of ABCG2 by PPARg was shown in myeloid cells
(Szatmari et al., 2006). The farnesol X receptor (FXR) is a bile acid recep-
tor mainly expressed in the liver and intestine and regulates bile acid
synthesis and transport (Kalaany and Mangelsdorf, 2006). Roles of
FXR have been demonstrated in the regulation of ABCB11 and ABCC2
(Ananthanarayanan et al., 2001; Kast et al., 2002). Teleost PPARs and
FXRs have been characterised (Leaver et al., 2005; Reschly et al., 2008;
Krasowski et al., 2011) but no data are available regarding their poten-
tial roles the regulation of ABC transporters.
5.4. Hormonal effects on ABC transporters
The glucocorticoid receptor (GR) is a nuclear receptor that binds
natural and synthetic glucocorticoids with high afﬁnity and mediates
genomic and non-genomic effects of these steroids (Bamberger et al.,
1996). In addition to classical “glucocorticoid” roles related to metabo-
lism, immune function, development and response to stressors (Yudt
and Cidlowski, 2002; Charmandari et al., 2005), the GR has central
roles in the osmoregulation of teleost ﬁsh (Bury and Sturm, 2007;
Kiilerich et al., 2011). The effects of glucocorticoids on Abcc2-
mediated transport were investigated in killiﬁsh kidney tubules
(Prevoo et al., 2011). The rapid stimulation of Abcc2-dependent trans-
port by the natural hormone cortisol and the synthetic glucocorticoids
dexamethasone was inhibited by the GR antagonist RU486 but was
insensitive to cycloheximide and actinomycin D, suggesting that
dexamethasone effects were mediated by GR in a non-genomic fashion
(Prevoo et al., 2011). The mechanism of dexamethasone activation
of renal Abcc2 activity involved the tyrosine receptor kinase c-MET
and MEK1/2 (mitogen-activated protein kinase/extracellular signal
regulated kinase kinase) (Prevoo et al., 2011).
The vasoconstrictive peptide hormone endothelin (ET) reduced the
luminal secretion of ABCB1 andABCC substrates by killiﬁsh proximal tu-
bules (Masereeuw et al., 2000). These effects of ET were mediated
through B-type ET receptor and involved protein kinase C (PKC)
(Masereeuw et al., 2000). Similar inhibitory effects of ET involving PKC
were shown on ABCC2-like transport in shark rectal gland (Miller and
Masereeuw, 2002). A role of PKC in Abcb1-dependent renal transport
in killiﬁsh had previously been shown (Miller et al., 1998b). Different
nephrotoxicants decreased Abcc2-dependent transport activity by the
ET -dependent pathway, most probably by causing an opening ofcalcium channels that resulted in an increase of intracellular Ca2+ levels
which in turn triggered ET secretion (Terlouw et al., 2001). Subsequent
studies demonstrated the involvement of nitric oxide synthase
and guanylyl cyclase signalling in regulation of Abcc2-activity by ET
(Notenboom et al., 2002, 2004). Another study investigated the effects
of calciotropic hormones on Abcc2-dependent transport in teleost
kidney (Wever et al., 2007). Parathyroid hormone (PTH) is a tetrapod
hypercalcemic hormone that has recently been shown to exist in teleost
ﬁsh, where its roles are unknown. In teleosts, the similar PTH-related
protein (PTHrP) functions as hypercalcemic hormone, stimulating calci-
um uptake fromwater, whereas stanniocalcin (STC) blocks calcium up-
take. PTH and PTHrP caused a similar partial inhibition of Abcc2-activity
as ET, and showed additive effects when given together with ET (Wever
et al., 2007). STC reversed the effects of PTHrP, but had no effect when
given alone (Wever et al., 2007).
5.5. Chemical effects on ABC transporter expression in ﬁsh
A limited number of studies have investigated the inducibility of ABC
drug transporters in ﬁsh by organic chemicals. Results obtainedwith PXR
and AhR agonists have been reviewed above. The effects of the feed adul-
terants melamine and cyanuric acid on renal ABC transporter transcript
levels were studied in a trial with rainbow trout (Oncorhynchus mykiss)
(Benedetto et al., 2011). While the study does not provide statistical
analyses, an apparent stimulation of abcc2mRNA levels was observed
when both compounds were combined (Benedetto et al., 2011). The
anti-parasitic compound emamectin benzoate (EMB), known to be an
ABCB1 substrate (Igboeli et al., 2012), was investigated regarding its
effects on ABC transporters in rainbow trout following a standard 7-day
administration ofmedicated feed (Cárcamoet al., 2011).Abcc1 transcripts
were up-regulated in all tissues investigated (liver, muscle, gill, kidney,
intestine), with effects being most pronounced in the intestine
(Cárcamo et al., 2011). In addition, a slight increase in hepatic and a
small decrease in intestinal abcb1 transcript abundances was observed
(Cárcamo et al., 2011). Waterborne exposure of juvenile rainbow
trout to the cholesterol-lowering drug atorvastatin provoked the up-
regulation of abcb1 and abcc1 transcripts in gill tissue (Ellesat et al.,
2012). The effects of heavy fuel oil and perﬂuorooctane sulfonate
(PFOS) on transcript levels of different ABC transporters (abcb1, 11,
abcc2, 3, abcg2) were studied in thicklip grey mullet (Chelon labrosus)
using a semi-quantitative RT-PCR method (Diaz de Cerio et al., 2012).
The authors observed moderate increases of abcb1, abcb11 and abcg2
mRNA levels in liver and of abcb11mRNA levels in brain following expo-
sure to PFOS, as well as complex changes in transporter expression in oil
and combined oil and PFOS treatments (Diaz de Cerio et al., 2012).
A number of studies provide evidence for a regulation of teleost ABC
drug efﬂux transporters by heavymetals. Exposure of killiﬁsh to sodium
arsenite for 4–14 days increased Abcc2 expression and activity in renal
proximal tubules, but did not affect abcc2 mRNA levels (Miller et al.,
2007). Pre-exposure of ﬁsh to sodium arsenite provided protection
against adverse effects of the metal on mitochondrial function in renal
tubules (Miller et al., 2007). Cadmium (Cd), mercury (Hg), lead (Pb)
and arsenic (As) stimulated the expression of abcc1 and abcc5 tran-
scripts in the zebraﬁsh cell line ZF4 (Long et al., 2011a,b). Overexpres-
sion of Abcc1 in zebraﬁsh embryos reduced the toxicity of Cd, Hg and
As (Long et al., 2011a). In contrast, abcc5 overexpression had protective
effects only with respect to Cd toxicity, but did not affect adverse effects
of Hg or As (Long et al., 2011b). Exposure of zebraﬁsh toHg and Pb stim-
ulated abcc2 transcription in intestine, liver and kidney (Long et al.,
2011d). Overexpression of abcc2 in ZF4 cells and embryos decreased
the cellular accumulation of Cd, Hg and Pb (Long et al., 2011d). The in-
teraction of toxic metals (Cd, Cr, Hg, As) with ABC drug transporters
was studied in the ﬁsh cell lines PLHC-1 (wild type) and PLHC-1/dox
(see above) (Della Torre et al., 2012). All metals upregulated mRNA ex-
pression of abcc2, abcc3 and abcc4, and inhibited Abcb1- and Abcc-like
transport activities (Della Torre et al., 2012). Prolonged exposure to
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mRNA levels of any of the transporters studied (Della Torre et al.,
2012). Abcb10, a mitochondrial ABC transporter associatedwith the cel-
lular response to oxidative stress, was signiﬁcantly upregulated in mus-
cle tissue of zebraﬁsh kept for 5 days in tanks with sediments spiked
with Cu and Cd. Abcb10 transcript levels were also increased in brain,
gill and intestinal tissues, albeit to a lesser extent (Sabri et al., 2012).
5.6. Altered ABC transporter expression in ﬁsh from polluted habitats
A number of studies have found altered expression of ABC drug
transporters in ﬁsh from polluted habitats. Using immunodetection
with the mAB C219, an elevated hepatic expression of ABCB1-like pro-
teins has been reported in killiﬁsh at a creosote-contaminated site
when compared to a control site (Cooper et al., 1999). In another
study, killiﬁsh from New Bedford Harbor (MA, USA), a habitat contam-
inated with planar halogenated aromatic hydrocarbons, showed de-
creased hepatic and increased intestinal levels of ABCB1-like proteins
when compared to ﬁsh from a reference site (Bard et al., 2002a). How-
ever, when ﬁsh were kept in uncontaminated water in the laboratory
for 11 weeks, hepatic levels of ABCB1-like proteins decreased in both
populations, whereas intestinal levels decreased only in ﬁsh from New
Bedford Harbor (Bard et al., 2002a). In another study with the intertidal
species cockscomb blenny, hepatic levels of ABCB1-like proteins were
elevated at sites affected by pulp mill efﬂuents, but there was no corre-
lation between transporter expression and the distance to the pollution
source (Bard et al., 2002b). ABCB1-like protein levels in liver decreased
aftermaintenance of ﬁsh under controlled laboratory conditions, but at-
tempts to induce hepatic transporters by exposure of blennies to con-
taminated sediment or prey items from the ﬁeld were unsuccessful
(Bard et al., 2002b). Asmentioned above, experimental treatment of kil-
liﬁsh with AhR agonists was without effect on ABCB1-like expression in
both killiﬁsh and cockscomb blennies (Cooper et al., 1999; Bard et al.,
2002a,b). Another study investigated ABC transporter expression in kil-
liﬁsh from the Sydney Tar Ponds, Nova Scotia, Canada, which are highly
contaminatedwith PAHs, PCBs and heavymetals (Paetzold et al., 2009).
Compared to reference site animals, Sydney Tar Pond killiﬁsh showed
increased hepatic transcript levels of abcc2, abcg2, cyp1a1 and gst-mu,
whereas abcb1 and abcb11 mRNA levels were unchanged (Paetzold
et al., 2009). Together, the above studies demonstrate that environmen-
tal pollutants can affect ABC transporter expression in ﬁsh; however, at
present, the exact identity of chemical inducers remains unclear. Com-
plicating the elucidation of possible links between pollutant exposure
and the expression of ABC pumps in the tissues of feralﬁsh, the possibil-
ity exists that chemicals of non-anthropogenic origin may have modu-
lated ABC transporter expression in ﬁsh, as exempliﬁed by the
induction of abcb1 mRNA levels and ABCB1-like protein in the gills
and liver of the teleost Jenynsia multidentata (Amé et al., 2009).
6. Summary and conclusions
In the last years, research on ABCdrug transporters in teleostﬁshhas
substantially advanced. Progress in the ﬁeld has been signiﬁcantly facil-
itated by the completion of different teleost genome projects, through
which ABC transporter sequences have become available and which
have enabled the annotation of the ABC gene family in zebraﬁsh and
catﬁsh; in addition, partially annoted ABC gene sequences of further
teleost species are publically available at the Ensembl Genome Browser
(www.ensembl.org). The comparison of the ABC family between ge-
nomes of teleosts and tetrapods revealed a number of clear orthologous
relationships that are consistent with the hypothesis of conserved
function. However, the presence of lineage-speciﬁc gene duplications,
particularly in teleosts, complicates the picture in some subfamilies
and further research is needed to elucidate the functional signiﬁcance
of the duplicated ABC transporter genes in teleosts.A number of studies have investigated the effects of exposure to
chemicals on mRNA levels of ABC transporters in teleost tissues using
quantitative RT-qPCR. While these works provide valuable insights
into the regulation of ABC drug transporters in teleosts, it needs to be
stressed that the relationship between mRNA abundance, transporter
protein expression and transporter activity is not necessarily straight-
forward, reﬂecting the complexity of the different modes of genomic
and non-genomic regulation of ABC proteins. In other words, the chal-
lenge is to linkmRNA levels to protein expression and transport activity.
While some progress has been achieved regarding transport assays of
improved speciﬁcity, the very limited availability of antibodies allowing
to detect speciﬁc ABC transporters in teleosts still represents a signiﬁ-
cant obstacle in understanding the regulation of ABCdrugpumps inﬁsh.
About two decades ago, results obtained by transport activity mea-
surements and immunochemical methods revealed that the tissue
distribution of the ABC drug transporter P-glycoprotein/Abcb1 in tele-
osts resembles that in mammals, suggesting similar functional proper-
ties and physiological roles of ABC pumps in both vertebrate groups.
Since then, ABC protein-dependent transport activities have been
characterised in a number of organ culture models from teleosts,
employing a range of ﬂuorescent probes and transporter inhibitors of
known speciﬁcity in mammals. In particular, isolated kidney tubules
of certain marine teleosts retain epithelial polarity and transport activi-
ties during short-term culture, and have proven a very useful model for
the investigation of renal drug transport in teleosts.
However, in vitro models are not available for all teleost tissues of
interest, which currently restricts feasible approaches to study ABC trans-
porter function in situ. E.g., very little is known on ABC transporter-
mediated processes at teleost branchial and intestinal epithelia. Given
the high importance of both the gills and the gut as surfaces forming
external body boundaries inﬁsh, studies elucidating the role of ABC trans-
porters in chemical uptake and elimination at these sites are urgently
needed to improve current models of chemical fate in ﬁsh. The activity
of hepatic ABCdrug transporters has been studied in a number of teleosts,
usually employing isolated cultured hepatocytes. However, the common
cell monolayer system of hepatocyte primary culture is not ideally suited
for transport studies, as cellular polarity is lost during cell isolation and
usually does not re-establish in culture. A number of alternative primary
culture systems has been proposed but these experimental model
systems remain as yet unexplored regarding their suitability for studies
of ABC transporters.
While isolated or cultured tissues are experimental systems
depicting the in vivo situationwith a certain degree of realism, such pri-
mary culturemodels usually contain a range of drug transporters,which
limits their usefulness in studies aiming at the characterisation of specif-
ic ABC transporters. Systems allowing functional studies of individual
ABC drug transporters have recently become available in teleosts and
include drug-selected cell lines overexpressing speciﬁc ABC drug trans-
porters, as well as insect cell/baculovirus systems suitable for the
recombinant expression of ABC pumps. Another approach to address
the functions of speciﬁc ABC transporters is provided by reverse genetic
methodologies such as gene knockdown studies in zebraﬁsh embryos.
Considering that certain ﬁsh species, such as zebraﬁsh, are increas-
ingly used as vertebratemodel systems in biomedical and ecotoxicolog-
ical research, it is of utmost importance to understand the biochemical
and cellular factors driving the toxicokinetic and toxicodynamic proper-
ties of chemicals. While the relevance of active transport mediated by
ABC transporters is well accepted in this regard in pharmacology, ABC
proteins have so far attracted only limited attention in aquatic toxicolo-
gy. It is hoped that the overview of the current state of ABC transporter-
related research in teleost ﬁsh provided in this article will stimulate
research further elucidating organ-speciﬁc roles of these transporters
as factors affecting the fate and biological effects of chemicals in ﬁsh.
In summary, while many details regarding the physiological func-
tion and ecotoxicological relevance of ABC transporters await being
clariﬁed in teleosts, there has been signiﬁcant progress in characterising
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have become available that allow addressing both fundamental ques-
tions of transporter regulation and function in teleosts, and applied as-
pects such as the interaction of ABC pumps with pharmacologically
and ecotoxicologically relevant chemicals. The aspects of chemical
transporter interaction need to be taken into account in studies address-
ing toxicokinetic and toxicodynamic processes of chemicals in ﬁsh.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.cbpc.2014.05.002.
Acknowledgements
TL and SF acknowledge support with travel grants from the
European Network on Fish Biomedical Models (EuFishBioMed; COST
Action BM0804) that enabled a meeting of the authors in Stirling to
complete a ﬁrst draft of the review article. AS gratefully acknowledges
support from the MASTS pooling initiative (The Marine Alliance
for Science and Technology for Scotland). MASTS is funded by the
Scottish Funding Council (grant reference HR09011) and contributing
institutions.
References
Abele, R., Tampé, R., 2006. Modulation of the antigen transport machinery TAP by friends
and enemies. FEBS Lett. 580, 1156–1163.
Albertus, J.A., Laine, R.O., 2001. Enhanced xenobiotic transporter expression in normal
teleost hepatocytes: response to environmental and chemotherapeutic toxins. J.
Exp. Biol. 204, 217–227.
Aleksandrov, A.A., Aleksandrov, L.A., Riordan, J.R., 2007. CFTR (ABCC7) is a hydrolyzable-
ligand-gated channel. Pﬂugers. Arch. 453, 693–702.
Allen, J.D., van Loevezijn, A., Lakhai, J.M., van der Valk, M., van Tellingen, O., Reid, G.,
Schellens, J.H.M., Koomen, G.-J., Schinkel, A.H., 2002. Potent and speciﬁc inhibition
of the breast cancer resistance protein multidrug transporter in vitro and in mouse
intestine by a novel analogue of fumitremorgin C. Mol. Cancer Ther. 1, 417–425.
Aller, S.G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., Harrell, P.M., Trinh, Y.T.,
Zhang, Q., Urbatsch, I.L., Chang, G., 2009. Structure of P-glycoprotein reveals a molec-
ular basis for poly-speciﬁc drug binding. Science 323, 1718–1722.
Ambudkar, S.V., Cardarelli, C.O., 1997. Relation between the turnover number for vinblastine
transport and for vinblastine-stimulatedATPhydrolysis by humanP-glycoprotein. J. Biol.
Chem. 272, 21160–21166.
Ambudkar, S.V., Lelong, I.H., Zhang, J., Cardarelli, C.O., Gottesman, M.M., Pastan, I., 1992.
Partial puriﬁcation and reconstitution of the human multidrug-resistance pump:
characterization of the drug-stimulatable ATP hydrolysis. Proc. Natl. Acad. Sci. U. S. A.
89, 8472–8476.
Ambudkar, S.V., Dey, S., Hrycyna, C.A., Ramachandra, M., Pastan, I., Gottesman, M.M.,
1999. Biochemical, cellular, andpharmacological aspects of themultidrug transporter.
Annu. Rev. Pharmacol. Toxicol. 39, 361–398.
Amé, M.V., Baroni, M.V., Galanti, L.N., Bocco, J.L., Wunderlin, D.A., 2009. Effects of
microcystin-LR on the expression of P-glycoprotein in Jenynsia multidentata.
Chemosphere 74, 1179–1186.
Amores, A., Force, A., Yan, Y.L., Joly, L., Amemiya, C., Fritz, A., Ho, R.K., Langeland, J., Prince,
V., Wang, Y.L., Westerﬁeld, M., Ekker, M., Postlethwait, J.H., 1998. Zebraﬁsh hox
clusters and vertebrate genome evolution. Science 282, 1711–1714.
Ananthanarayanan, M., Balasubramanian, N., Makishima, M., Mangelsdorf, D.J., Suchy, F.J.,
2001. Human bile salt export pump promoter is transactivated by the farnesoid X
receptor/bile acid receptor. J. Biol. Chem. 276, 28857–28865.
Annilo, T., Chen, Z.-Q., Shulenin, S., Costantino, J., Thomas, L., Lou, H., Stefanov, S., Dean, M.,
2006. Evolution of the vertebrate ABC gene family: analysis of gene birth and death.
Genomics 88, 1–11.
Annilo, T., Dean, M., 2004. Degeneration of an ATP-binding cassette transporter gene,
ABCC13, in different mammalian lineages. Genomics 84, 34–46.
Aparicio, S., 2000. Vertebrate evolution: recent perspectives from ﬁsh. Trends Genet. 16,
54–56.
Baehr, C.H., Fricker, G., Miller, D.S., 2006. Fluorescein-methotrexate transport in dogﬁsh
shark (Squalus acanthias) choroid plexus. Am. J. Physiol. Regul. Integr. Comp. Physiol.
291, R464–R472.
Bain, L.J., LeBlanc, G.A., 1996. Interaction of structurally diverse pesticides with the human
MDR1 gene product P-glycoprotein. Toxicol. Appl. Pharmacol. 141, 288–298.
Bain, L.J., McLachlan, J.B., LeBlanc, G.A., 1997. Structure-activity relationships for xenobiotic
transport substrates and inhibitory ligands of P-glycoprotein. Environ.Health Perspect.
105, 812–818.
Bains, O.S., Kennedy, C.J., 2005. Alterations in respiration rate of isolated rainbow trout
hepatocytes exposed to the P-glycoprotein substrate rhodamine 123. Toxicology
214, 87–98.
Bakke, A.M., Glover, C., Krogdahl, A., 2011. Feeding, digestion and absorption of nutrients.
In: Grosell, M., Farrell, A.P., Brauner, C. (Eds.), The Multifunctionall Gut of Fish.
Elsevier, Amsterdam, The Netherlands, pp. 57–110.
Bakos, E., Homolya, L., 2007. Portrait of multifaceted transporter, the multidrug
resistance-associated protein 1 (MRP1/ABCC1). Pﬂugers Arch. 453, 621–641.Ballatori, N., Rebbeor, J.F., Connolly, G.C., Seward, D.J., Lenth, B.E., Henson, J.H., Sundaram,
P., Boyer, J.L., 2000. Bile salt excretion in skate liver is mediated by a functional analog
of Bsep/Spgp, the bile salt export pump. Am. J. Physiol. Gastrointest. Liver Physiol.
278, G57–G63.
Bamberger, C.M., Schulte, H.M., Chrousos, G.P., 1996. Molecular determinants of glucocor-
ticoid receptor function and tissue sensitivity to glucocorticoids. Endocr. Rev. 17,
245–261.
Bard, S.M., 2000. Multixenobiotic resistance as a cellular defense mechanism in aquatic
organisms. Aquat. Toxicol. 48, 357–389.
Bard, S.M., Gadbois, S., 2007. Assessing neuroprotective P-glycoprotein activity at the
blood–brain barrier in killiﬁsh (Fundulus heteroclitus) using behavioural proﬁles.
Mar. Environ. Res. 64, 679–682.
Bard, S.M., Bello, S.M., Hahn, M.E., Stegeman, J.J., 2002a. Expression of P-glycoprotein in
killiﬁsh (Fundulus heteroclitus) exposed to environmental xenobiotics. Aquat. Toxicol.
59, 237–251.
Bard, S.M., Woodin, B.R., Stegeman, J.J., 2002b. Expression of P-glycoprotein and cyto-
chrome p450 1A in intertidal ﬁsh (Anoplarchus purpurescens) exposed to environ-
mental contaminants. Aquat. Toxicol. 60, 17–32.
Barrand, M., Rhodes, T., Center, M., Twentyman, P., 1993. Chemosensitisation and drug ac-
cumulation effects of cyclosporin A, PSC-833 and verapamil in humanMDR large cell
lung cancer cells expressing a 190 k membrane protein distinct from P-glycoprotein.
Eur. J. Cancer 29A, 408–415.
Belanger, S.E., Rawlings, J.M., Carr, G.J., 2013. Use of ﬁsh embryo toxicity tests for the
prediction of acute ﬁsh toxicity to chemicals. Environ. Toxicol. Chem. 32, 1768–1783.
Benedetto, A., Squadrone, S., Prearo, M., Elia, A.C., Giorgi, I., Abete, M.C., 2011. Evalu-
ation of ABC efﬂux transporters genes expression in kidney of rainbow trout
(Oncorhynchus mykiss) fed with melamine and cyanuric acid diets. Chemosphere
84, 727–730.
Bergen, A.A.B., Plomp, A.S., Hu, X., De Jong, P.T.V.M., Gorgels, T.G.M.F., 2007. ABCC6 and
pseudoxanthoma elasticum. Pﬂugers. Arch. 453, 685–691.
Bertilsson, G., Heidrich, J., Svensson, K., Asman, M., Jendeberg, L., Sydow-Bäckman, M.,
Ohlsson, R., Postlind, H., Blomquist, P., Berkenstam, A., 1998. Identiﬁcation of a
human nuclear receptor deﬁnes a new signaling pathway for CYP3A induction.
Proc. Natl. Acad. Sci. U. S. A. 95, 12208–12213.
Beyenbach, K.W., 2004. Kidneys sans glomeruli. Am. J. Physiol. Ren. Physiol. 286,
F811–F827.
Black, J.J., Baumann, P.C., 1991. Carcinogens and cancers in freshwater ﬁshes. Environ.
Health Perspect. 90, 27–33.
Blumberg, B., Sabbagh Jr., W., Juguilon, H., Bolado Jr., J., van Meter, C.M., Ong, E.S.,
Evans, R.M., 1998. SXR, a novel steroid and xenobioticsensing nuclear receptor.
Genes Dev. 12, 3195–3205.
Bone, Q., Moore, R.H., 2008. Biology of ﬁshes, 3rd ed. Taylor & Francis, New York,.
Borst, P., Zelcer, N., van deWetering, K., Poolman, B., 2006. On the putative co-transport of
drugs by multidrug resistance proteins. FEBS Lett. 580, 1085–1093.
Borst, P., de Wolf, C., van de Wetering, K., 2007. Multidrug resistance-associated proteins
3, 4, and 5. Pﬂugers Arch. 453, 661–673.
Bosnjak, I., Uhlinger, K.R., Heim, W., Smital, T., Franekić-Colić, J., Coale, K., Epel, D.,
Hamdoun, A., 2009. Multidrug efﬂux transporters limit accumulation of inorganic,
but not organic, mercury in sea urchin embryos. Environ. Sci. Technol. 43, 8374–8380.
Bouige, P., Laurent, D., Piloyan, L., Dassa, E., 2002. Phylogenetic and functional classiﬁca-
tion of ATP-binding cassette (ABC) systems. Curr. Protein Pept. Sci. 3, 541–559.
Bradbury, S., Coats, J., Mckim, J.M., 1986. Toxicokinetics of fenvalerate in rainbow trout
(Salmo gairdneri). Environ. Toxicol. Chem. 5, 567–576.
Bryan, J., Muñoz, A., Zhang, X., Düfer, M., Drews, G., Krippeit-Drews, P., Aguilar-Bryan, L.,
2007. ABCC8 and ABCC9: ABC transporters that regulate K+ channels. Pﬂugers.
Arch. - Eur. J. Physiol. 453, 703–718.
Bresolin, T., Rebelo, M.D., Bainy, A.C.D., 2005. Expression of PXR, CYP3A and MDR1 genes
in liver of zebraﬁsh. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 140, 403–407.
Bridges, C.C., Joshee, L., Zalups, R.K., 2008. MRP2 and the DMPS- and DMSA-mediated
elimination of mercury in TR(−) and control rats exposed to thiol S-conjugates of
inorganic mercury. Toxicol. Sci. 105, 211–220.
Broeks, A., Gerrard, B., Allikmets, R., Dean, M., Plasterk, R.H., 1996. Homologues of the
human multidrug resistance genes MRP and MDR contribute to heavy metal resis-
tance in the soil nematode Caenorhabditis elegans. EMBO J. 15, 6132–6143.
Bunting, K.D., 2002. ABC transporters as phenotypic markers and functional regulators of
stem cells. Stem Cells 20, 11–20.
Burke, M.A., Ardehali, H., 2007. Mitochondrial ATP-binding cassette proteins. Transl. Res.
150, 73–80.
Burt, R.K., Thorgeirsson, S.S., 1988. Coinduction of MDR-1 multidrug-resistance and cyto-
chrome P-450 genes in rat liver by xenobiotics. J. Natl. Cancer Inst. 80, 1383–1386.
Bury, N.R., Sturm, A., 2007. Evolution of the corticosteroid receptor signalling pathway in
ﬁsh. Gen. Comp. Endocrinol. 153, 47–56.
Cai, S.Y., Wang, L., Ballatori, N., Boyer, J.L., 2001. Bile salt export pump is highly conserved
during vertebrate evolution and its expression is inhibited by PFIC type II mutations.
Am. J. Physiol. Gastrointest. Liver Physiol. 281, G316–G322.
Cai, S.Y., Soroka, C.J., Ballatori, N., Boyer, J.L., 2003. Molecular characterization of a multi-
drug resistance-associated protein, Mrp2, from the little skate. Am. J. Physiol. Regul.
Integr. Comp. Physiol. 284, R125–R130.
Cain, K., Swan, C., 2011. Barrier function and immunology. In: Grosell, M., Farrell, A.P.,
Brauner, C.J. (Eds.), Fish Physiology: The Multifunctional Gut of Fish. Elsevier,
Amsterdam, The Netherlands, pp. 112–135.
Calcagno, A.M., Kim, I.-W., Wu, C.-P., Shukla, S., Ambudkar, S.V., 2007. ABC drug
transporters as molecular targets for the prevention of multidrug resistance and
drug–drug interactions. Curr. Drug Deliv. 4, 324–333.
Caminada, D., Zaja, R., Smital, T., Fent, K., 2008. Human pharmaceuticals modulate P-gp1
(ABCB1) transport activity in the ﬁsh cell line PLHC-1. Aquat. Toxicol. 90, 214–222.
48 T. Luckenbach et al. / Comparative Biochemistry and Physiology, Part C 165 (2014) 28–52Cárcamo, J.G., Aguilar, M.N., Barrientos, C.A., Carreño, C.F., Quezada, C.A., Bustos, C.,
Manríquez, R.A., Avendaño-Herrera, R., Yañez, A.J., 2011. Effect of emamectin
benzoate on transcriptional expression of cytochromes P450 and the multidrug
transporters (Pgp and MRP1) in rainbow trout (Oncorhynchus mykiss) and the sea
lice Caligus rogercresseyi. Aquaculture 321, 207–215.
Chan, K.M., 1992. P-glycoprotein genes in the winter ﬂounder, Pleuronectes americanus:
isolation of two types of genomic clones carrying 3’ terminal exons. Biochim. Biophys.
Acta 1171, 65–72.
Chan, L., 2004. The ABCs of drug transport in intestine and liver: efﬂux proteins limiting
drug absorption and bioavailability. Eur. J. Pharm. Sci. 21, 25–51.
Chan, G.N.Y., Hoque, M.T., Bendayan, R., 2013. Role of nuclear receptors in the regulation
of drug transporters in the brain. Trends Pharmacol. Sci. 34, 361–372.
Charmandari, E., Tsigos, C., Chrousos, G., 2005. Endocrinology of the stress response.
Annu. Rev. Physiol. 67, 259–284.
Chen, K.G., Sikic, B.I., 2012. Molecular pathways: regulation and therapeutic implications
of multidrug resistance. Clin. Cancer Res. 18, 1863–1869.
Chen, Y., Tang, Y., Guo, C., Wang, J., Boral, D., Nie, D., 2012. Nuclear receptors in the
multidrug resistance through the regulation of drug-metabolizing enzymes and
drug transporters. Biochem. Pharmacol. 83, 1112–1126.
Childs, S., Yeh, R.L., Georges, E., Ling, V., 1995. Identiﬁcation of a sister gene to P-glycoprotein.
Cancer Res. 55, 2029–2034.
Choi, C.-H., 2005. ABC transporters as multidrug resistance mechanisms and the develop-
ment of chemosensitizers for their reversal. Cancer Cell Int. 5, 30.
Cole, S.P.C., Bhardwaj, G., Gerlach, J.H., Mackie, J.E., Grant, C.E., Almquist, K.C., Stewart, A.J.,
Kurz, E.U., Duncan, A.M.V., Deeley, R.RG., 1992. Overexpression of a transporter gene
in a multidrug-resistant human lung cancer cell line. Science 258, 1650–1654.
Collier, T.K., Varanasi, U., 1991. Hepatic activities of xenobiotic metabolizing enzymes and
biliary levels of xenobiotics in English sole (Parophrys vetulus) exposed to environ-
mental contaminants. Arch. Environ. Contam. Toxicol. 20, 462–473.
Cooper, P.S., Vogelbein, W.K., Van Veld, P.A., 1999. Altered expression of the xenobiotic
transporter P-glycoprotein in liver and liver tumours of mummichog (Fundulus
heteroclitus) from a creosote-contaminated environment. Biomarkers 4, 48–58.
Costa, J., Reis-Henriques, M.A., Castro, L.F.C., Ferreira, M., 2012. Gene expression analysis
of ABC efﬂux transporters, CYP1A and GSTα in Nile tilapia after exposure to
benzo(a)pyrene. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 155, 469–482.
Crivellato, E., Candussio, L., Rosati, A.M., Bartoli-Klugmann, F.,Mallardi, F., Decorti, G., 2002.
The ﬂuorescent probe Bodipy-FL-verapamil is a substrate for both P-glycoprotein and
multidrug resistance-related protein (MRP)-1. J. Histochem. Cytochem. 50, 731–734.
Crone, C., Christensen, O., 1981. Electrical resistance of a capillary endothelium. J. Gen.
Physiol. 77, 349–371.
Cserr, H.F., Bundgaard, M., 1984. Blood–brain interfaces in vertebrates: a comparative
approach. Am. J. Physiol. Regul. Integr. Comp. Physiol. 246, R277–R288.
Dallas, S., Miller, D.S., Bendayan, R., 2006. Multidrug resistance-associated proteins:
expression and function in the central nervous system. Pharmacol. Rev. 58, 140–161.
Dean, M., Annilo, T., 2005. Evolution of the ATP-binding cassette (ABC) transporter super-
family in vertebrates. Annu. Rev. Genomics Hum. Genet. 6, 123–142.
Dean, M., Rzhetsky, A., Allikmets, R., 2001. The human ATP-binding cassette (ABC) trans-
porter superfamily. Genome Res. 11, 1156–1166.
Deeley, R.G., Cole, S.P.C., 2006. Substrate recognition and transport by multidrug resis-
tance protein 1 (ABCC1). FEBS Lett. 580, 1103–1111.
Deeley, R.G., Westlake, C., Cole, S.P.C., 2006. Transmembrane transport of endo- and xeno-
biotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol.
Rev. 86, 849–899.
Della Torre, C., Zaja, R., Loncar, J., Smital, T., Focardi, S., Corsi, I., 2012. Interaction of ABC
transport proteins with toxic metals at the level of gene and transport activity in
the PLHC-1 ﬁsh cell line. Chem. Biol. Interact. 198, 9–17.
Deng, L., Lin-Lee, Y.C., Claret, F.X., Kuo, M.T., 2001. 2-acetylaminoﬂuorene up-regulates rat
mdr1b expression through generating reactive oxygen species that activate NF-kappa
B pathway. J. Biol. Chem. 276, 413–420.
Diaz de Cerio, O., Bilbao, E., Cajaraville, M.P., Cancio, I., 2012. Regulation of xenobiotic
transporter genes in liver and brain of juvenile thicklip greymullets (Chelon labrosus)
after exposure to Prestige-like fuel oil and to perﬂuorooctane sulfonate. Gene 498,
50–58.
Doi, A.M., Holmes, E., Kleinow, K.M., 2001. P-glycoprotein in the catﬁsh intestine: induc-
ibility by xenobiotics and functional properties. Aquat. Toxicol. 55, 157–170.
Doige, C.A., Yu, X., Sharom, F.J., 1992. ATPase activity of partially puriﬁed P-glycoprotein
from multidrug-resistant Chinese hamster ovary cells. Biochim. Biophys. Acta 1109,
149–160.
Dussault, I., Lin, M., Hollister, K., Wang, E.H., Synold, T.W., Forman, B.M., 2001. Peptide
mimetic HIV protease inhibitors are ligands for the orphan receptor SXR. J. Biol.
Chem. 276, 33309–33312.
Ebert, B., Seidel, A., Lampen, A., 2005. Identiﬁcation of BCRP as transporter of benzo[a]
pyrene conjugates metabolically formed in Caco-2 cells and its induction by
Ah-receptor agonists. Carcinogenesis 26, 1754–1763.
Ekins, S., Reschly, E.J., Hagey, L.R., Krasowski, M.D., 2008. Evolution of pharmacologic
speciﬁcity in the pregnane X receptor. BMC Evol. Biol. 8, 103.
Ellesat, K.S., Holth, T.F., Wojewodzic, M.W., Hylland, K., 2012. Atorvastatin up-regulate
toxicologically relevant genes in rainbow trout gills. Ecotoxicology 21, 1841–1856.
El-Sheikh, A.A.K., Masereeuw, R., Russel, F.G.M., 2008. Mechanisms of renal anionic drug
transport. Eur. J. Pharmacol. 585, 245–255.
Escriva, H., Manzon, L., Youson, J., Laudet, V., 2002. Analysis of lamprey and hagﬁsh genes
reveals a complex history of gene duplications during early vertebrate evolution. Mol.
Biol. Evol. 19, 1440–1450.
Essodaigui, M., Broxterman, H.J., Garnier-Suillerot, A., 1998. Kinetic analysis of calcein and
calcein-acetoxymethylester efﬂux mediated by the multidrug resistance protein and
P-glycoprotein. Biochemistry 37, 2243–2250.Estudante, M., Morais, J.G., Soveral, G., Benet, L.Z., 2013. Intestinal drug transporters: an
overview. Adv. Drug Deliv. Rev. 65, 1340–1356.
Evans, D.H., Piermarini, P.M., Choe, K.P., 2005. The multifunctional ﬁsh gill: dominant site
of gas exchange, osmoregulation, acid-base regulation, and excretion of nitrogenous
waste. Physiol. Rev. 85, 97–177.
Eytan, G.D., Regev, R., Assaraf, Y.G., 1996a. Functional reconstitution of P-glycoprotein re-
veals an apparent near stoichiometric drug transport to ATP hydrolysis. J. Biol. Chem.
271, 3172–3178.
Eytan, G.D., Regev, R., Oren, G., Assaraf, Y.G., 1996b. The role of passive transbilayer drug
movement in multidrug resistance and its modulation. J. Biol. Chem. 271,
12897–12902.
Fardel, O., Lecureur, V., Corlu, A., Guillouzo, A., 1996. P-glycoprotein induction in rat liver
epithelial cells in response to acute 3-methylcholanthrene treatment. Biochem.
Pharmacol. 51, 1427–1436.
Feige, J.N., Gelman, L., Michalik, L., Desvergne, B., Wahli, W., 2006. From molecular
action to physiological outputs: peroxisome proliferator-activated receptors
are nuclear receptors at the crossroads of key cellular functions. Prog. Lipid
Res. 45, 120–159.
Fidler, A.E., Holland, P.T., Reschly, E.J., Ekins, S., Krasowski, M.D., 2012. Activation of a
tunicate (Ciona intestinalis) xenobiotic receptor orthologue by both natural toxins
and synthetic toxicants. Toxicon 59, 365–372.
Fischer, S., Pietsch, M., Schirmer, K., Luckenbach, T., 2010. Identiﬁcation of multi-drug
resistance associated proteins MRP1 (ABCC1) and MRP3 (ABCC3) from rainbow
trout (Oncorhynchus mykiss). Mar. Environ. Res. 69 (Suppl.), S7–S10.
Fischer, S., Loncar, J., Zaja, R., Schnell, S., Schirmer, K., Smital, T., Luckenbach, T., 2011.
Constitutive mRNA expression and protein activity levels of nine ABC efﬂux trans-
porters in seven permanent cell lines derived from different tissues of rainbow
trout (Oncorhynchus mykiss). Aquat. Toxicol. 101, 438–446.
Fischer, S., Klüver, N., Burkhardt-Medicke, K., Pietsch, M., Schmidt, A.-M., Wellner, P.,
Schirmer, K., Luckenbach, T., 2013. Abcb4 acts as multixenobiotic transporter and
active barrier against chemical uptake in zebraﬁsh (Danio rerio) embryos. BMC Biol.
11, 69.
Fojo, A.T., Ueda, K., Slamon, D.J., Poplack, D.G., Gottesman, M.M., Pastan, I., 1987. Expres-
sion of a multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad.
Sci. U. S. A. 84, 265–269.
Ford, J.M., Hait, W.N., 1990. Pharmacology of drugs that alter multidrug resistance in
cancer. Pharmacol. Rev. 42, 155–199.
Ford, J.M., Hait, W.N., 1993. Pharmacologic circumvention of multidrug resistance.
Cytotechnology 12, 171–212.
Frank, N., Frank, M., 2009. ABCB5 gene ampliﬁcation in human leukemia cells. Leuk. Res.
33, 1303–1305.
Frank, N.Y., Pendse, S.S., Lapchak, P.H., Margaryan, A., Shlain, D., Doeing, C., Sayegh,
M.H., Frank, M.H., 2003. Regulation of progenitor cell fusion by ABCB5 P-
glycoprotein, a novel human ATP-binding cassette transporter. J. Biol. Chem.
278, 47156–47165.
Fricker, G., Gutmann, H., Droulle, A., Drewe, J., 1999. Epithelial transport of anthelmintic
ivermectin in a novel model of isolated proximal kidney tubules. Pharm. Res. 16,
1570–1575.
Gant, T.W., Silverman, J.A., Bisgaard, H.C., Burt, R.K., Marino, P.A., Thorgeirson, S.S., 1991.
Regulation of 2-acetylaminoﬂuorene- and 3-methylcholanthrene-mediated induc-
tion of multidrug resistance and cytochrome P450IA gene family expression in
primary hepatocyte cultures and rat liver. Mol. Carcinog. 4, 499–509.
Garcia-Fernandez, J., Holland, P.W., 1994. Archetypal organization of the amphioxus Hox
gene cluster. Nature 370, 563–566.
Gardner, E.R., Smith, N.F., Figg, W.D., Sparreboom, A., 2009. Inﬂuence of the dual ABCB1
and ABCG2 inhibitor tariquidar on the disposition of oral imatinib in mice. J. Exp.
Clin. Cancer Res. 28, 99.
Garrigues, A., Escargueil, A.E., Orlowski, S., 2002. The multidrug transporter, P-glycoprotein,
actively mediates cholesterol redistribution in the cell membrane. Proc. Natl. Acad. Sci.
U. S. A. 99, 10347–10352.
Geick, A., Eichelbaum, M., Burk, O., 2001. Nuclear receptor response elements mediate
induction of intestinal MDR1 by rifampin. J. Biol. Chem. 276, 14581–14587.
Gekeler, V., Ise, W., Sanders, K.H., Ulrich, W.-R., Beck, J., 1995. The leukotriene LTD4 recep-
tor antagonist MK571 speciﬁcally modulates MRP associated multidrug resistance.
Biochem. Biophys. Res. Commun. 208, 345–352.
Georges, E., Bradley, G., Gariepy, J., Ling, V., 1990. Detection of P-glycoprotein by gene-
speciﬁc monoclonal antibodies. Proc. Natl. Acad. Sci. U. S. A. 87, 152–156.
Gerloff, T., Stieger, B., Hagenbuch, B., Madon, J., Landmann, L., Roth, J., Hofmann, A.F.,
Meier, P.J., 1998. The sister of P-glycoprotein represents the canalicular bile salt
export pump of mammalian liver. J. Biol. Chem. 273, 10046–10050.
Germann, U., 1998. Baculovirus-mediated expression of human multidrug resistance
cDNA in insect cells and functional analysis of recombinant P-glycoprotein. Methods
Enzymol. 292, 427–441.
Goto, T., Holzinger, F., Hagey, L.R., Cerrè, C., Ton-Nu, H.-T., Schteingart, C.D., Steinbach,
J.H., Shneider, B.L., Hofmann, A.F., 2003. Physicochemical and physiological prop-
erties of 5alpha-cyprinol sulfate, the toxic bile salt of cyprinid ﬁsh. J. Lipid Res. 44,
1643–1651.
Gottesman, M.M., Fojo, T., Bates, S.E., 2002. Multidrug resistance in cancer: role of ATP-
dependent transporters. Nat. Rev. Cancer 2, 48–58.
Gourley, M.E., Kennedy, C.J., 2009. Energy allocations to xenobiotic transport and
biotransformation reactions in rainbow trout (Oncorhynchus mykiss) during en-
ergy intake restriction. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 150,
270–278.
Gros, P., Croop, J., Housman, D., 1986. Mammalian multidrug resistance gene: complete
cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47,
371–380.
49T. Luckenbach et al. / Comparative Biochemistry and Physiology, Part C 165 (2014) 28–52Gutmann, H., Fricker, G., Drewe, J., Toeroek, M., Miller, D.S., 1999. Interactions of HIV
protease inhibitors with ATP-dependent drug export proteins. Mol. Pharmacol. 56,
383–389.
Gutmann, H., Miller, D.S., Droulle, A., Drewe, J., Fahr, A., Fricker, G., 2000. P-glycoprotein-
and mrp2-mediated octreotide transport in renal proximal tubule. Br. J. Pharmacol.
129, 251–256.
Hahn, M.E., 1998. The aryl hydrocarbon receptor: a comparative perspective. Comp.
Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol. 121, 23–53.
Hamdoun, A., Epel, D., 2007. Embryo stability and vulnerability in an always changing
world. Proc. Natl. Acad. Sci. U. S. A. 104, 1745–1750.
Handschin, C., Blättler, S., Roth, A., Looser, R., Oscarson, M., Kaufmann, M.R., Podvinec, M.,
Gnerre, C., Meyer, U.A., 2004. The evolution of drug-activated nuclear receptors: one
ancestral gene diverged into two xenosensor genes in mammals. Nucl. Recept. 2, 7.
Hazard, S.E., Patel, S.B., 2007. Sterolins ABCG5 and ABCG8: regulators of whole body
dietary sterols. Pﬂugers Arch. 453, 745–752.
Helfman, G.S., Collette, B.B., Facey, D.E., Bowen, B.W., 2009. The diversity of ﬁshes, 2nd ed.
John Wiley, Oxford, UK,.
Hemmer, M., Courtney, L., Ortego, L., 1995. Immunohistochemical detection of P-
glycoprotein in teleost tissues usingmammalian polyclonal andmonoclonal antibodies.
J. Exp. Zool. 272, 69–77.
Hemmer, M., Courtney, L., Benson, W., 1998. Comparison of three histological ﬁxatives on
the immunoreactivity of mammalian P-glycoprotein antibodies in the sheepshead
minnow, Cyprinodon variegatus. J. Exp. Zool. 281, 251–259.
Herget,M., Tampé, R., 2007. Intracellular peptide transporters inhuman–compartmentalization
of the "peptidome". Pﬂugers Arch. 453, 591–600.
Hibino, H., Kurachi, Y., 2006. A new insight into the pathogenesis of coronary vasospasm.
Circ. Res. 98, 579–581.
Higgins, C.F., 1992. ABC transporters: frommicroorganism to man. Annu. Rev. Cell Biol. 8,
67–113.
Hildebrand, J.L., Bains, O.S., Lee, D.S.H., Kennedy, C.J., 2009. Functional and energetic char-
acterization of P-gp-mediated doxorubicin transport in rainbow trout (Oncorhynchus
mykiss) hepatocytes. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 149, 65–72.
Hinton, D.E., Segner, H., Au, D.W., Kullman, S.W., Hardman, R.C., 2008. Liver toxicity. In: Di
Giulio, R., Hinton, D.E. (Eds.), The Toxicology of Fishes. CRC Press, Boca Raton, FL, USA,
pp. 327–400.
Holló, Z., Homolya, L., Davis, C., Sarkadi, B., 1994. Calcein accumulation as a ﬂuorometric
functional assay of the multidrug transporter. Biochim. Biophys. Acta Biomembr.
1191, 384–388.
Holló, Z., Homolya, L., Hegedüs, T., Sarkadi, B., 1996. Transport properties of themultidrug
resistance-associated protein (MRP) in human tumour cells. FEBS Lett. 383, 99–104.
Homolya, L., Holló, Z., Germann, U., Pastan, I., Gottesman,M.M., Sarkadi, B., 1993. Fluorescent
cellular indicators are extruded by the multidrug-resistance protein. J. Biol. Chem. 268.
Høy, T., Horsberg, E., Nafstad, I., 1990. The disposition of ivermectin in Atlantic salmon
(Salmo salar). Pharmacol. Toxicol. 67, 307–312.
Igboeli, O.O., Fast, M.D., Heumann, J., Burka, J.F., 2012. Role of P-glycoprotein in
emamectin benzoate (SLICE(r)) resistance in sea lice, Lepeophtheirus salmonis. Aqua-
culture 344–349, 40–47.
Ishikawa, T., Bao, J.J., Yamane, Y., Akimaru, K., Frindrich, K., Wright, C.D., Kuo, M.T., 1996.
Coordinated induction of MRP/GS-X pump and gamma-glutamylcysteine synthetase
by heavy metals in human leukemia cells. J. Biol. Chem. 271, 14981–14988.
Jaillon, O., Aury, J.-M., Brunet, F., Petit, J.-L., Stange-Thomann, N., et al., 2004. Genome
duplication in the teleost ﬁsh Tetraodon nigroviridis reveals the early vertebrate
proto-karyotype. Nature 431, 946–957.
Jeong, J.-Y., Kwon, H.-B., Ahn, J.-C., Kang, D., Kwon, S.-H., Park, J.A., Kim, K.-W., 2008. Func-
tional and developmental analysis of the blood–brain barrier in zebraﬁsh. Brain Res.
Bull. 75, 619–628.
Johnson, K.R., Wright, J.E., May, B., 1987. Linkage relationships reﬂecting ancestral tetra-
ploidy in salmonid ﬁsh. Genetics 116, 579–591.
Jones, S.A., Moore, L.B., Shenk, J.L., Wisely, G.B., Hamilton, G.A., McKee, D.D.,
Tomkinson, N.C., LeCluyse, E.L., Lambert, M.H., Willson, T.M., Kliewer, S.A.,
Moore, J.T., 2000. The pregnane X receptor: a promiscuous xenobiotic receptor
that has diverged during evolution. Mol. Endocrinol. 14, 27–39.
Jonker, J.W., Buitelaar, M., Wagenaar, E., Van Der Valk, M.A., Scheffer, G.L., Scheper, R.J.,
Plösch, T., Kuipers, F., Oude Elferink, R.P.J., Rosing, H., Beijnen, J.H., Schinkel, A.H.,
2002. The breast cancer resistance protein protects against a major chlorophyll-
derived dietary phototoxin and protoporphyria. Proc. Natl. Acad. Sci. U. S. A. 99,
15649–15654.
Kalaany, N.Y., Mangelsdorf, D.J., 2006. LXRS and FXR: the yin and yang of cholesterol and
fat metabolism. Annu. Rev. Physiol. 68, 159–191.
Kast, H.R., Goodwin, B., Tarr, P.T., Jones, S.A., Anisfeld, A.M., Stoltz, C.M., Tontonoz, P.,
Kliewer, S., Willson, T.M., Edwards, P.A., 2002. Regulation of multidrug resistance-
associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid
X-activated receptor, and constitutive androstane receptor. J. Biol. Chem. 277,
2908–2915.
Katharios, P., Pavlidis, M., Iliopoulou-Georgudaki, J., 2004. Accumulation of ivermectin in
the brain of sea bream, Sparus aurata after intraperitoneal administration. Environ.
Toxicol. Pharmacol. 17, 9–12.
Kiilerich, P., Milla, S., Sturm, A., Valotaire, C., Chevolleau, S., Giton, F., Terrien, X., Fiet, J.,
Fostier, A., Debrauwer, L., Prunet, P., 2011. Implication of the mineralocorticoid axis
in rainbow trout osmoregulation during salinity acclimation. J. Endocrinol. 209,
221–235.
Kim, R.B., Fromm, M.F., Wandel, C., Leake, B., Wood, A.J.J., Roden, D.M., Wilkinson, G.R.,
1998. The drug transporter P-glycoprotein limits oral absorption and brain entry of
HIV-1 protease inhibitors. J. Clin. Invest. 101, 289–294.
Kipp, H., Arias, I.M., 2002. Trafﬁcking of canalicular ABC transporters in hepatocytes.
Annu. Rev. Physiol. 64, 595–608.Kleinow, K.M., Doi, A.M., Smith, A.A., 2000. Distribution and inducibility of P-glycoprotein
in the catﬁsh: immunohistochemical detection using the mammalian C-219
monoclonal. Mar. Environ. Res. 50, 313–317.
Kleinow, K.M., Hummelke, G.C., Zhang, Y., Uppu, P., Baillif, C., 2004. Inhibition of
P-glycoprotein transport: a mechanism for endocrine disruption in the channel
catﬁsh? Mar. Environ. Res. 58, 205–208.
Kleinow, K.M., Nichols, J.W., Hayton, W.L., Mckim, J.M., Barron, M.G., 2008. Toxicokinetics
in Fishes, in: The Toxicology of Fishes. CRC Press, Boca Raton, FL, USA, pp. 55–152.
Kliewer, S.A., Moore, J.T., Wade, L., Staudinger, J.L., Watson, M.A., Jones, S.A., McKee, D.D.,
Oliver, B.B., Willson, T.M., Zetterström, R.H., Perlmann, T., Lehmann, J.M., 1998. An
orphan nuclear receptor activated by pregnanes deﬁnes a novel steroid signaling
pathway. Cell 92, 73–82.
Kobayashi, H., Parton, A., Czechanski, A., Durkin, C., Kong, C., Barnes, D., 2007. Multidrug
resistance-associated protein 3 (Mrp3/Abcc3/Moat-D) is expressed in the SAE
Squalus acanthias shark embryo-derived cell line. Zebraﬁsh 4, 261–275.
Kobayashi, I., Saito, K., Moritomo, T., Araki, K., Takizawa, F., Nakanishi, T., 2008. Character-
ization and localization of side population (SP) cells in zebraﬁsh kidney hematopoi-
etic tissue. Blood 111, 1131–1137.
Koehler, A., Alpermann, T., Lauritzen, B., Van Noorden, C.J.F., 2004. Clonal xenobiotic resis-
tance during pollution-induced toxic injury and hepatocellular carcinogenesis in liver
of female ﬂounder (Platichthys ﬂesus (L.)). Acta Histochem. 106, 155–170.
Koepsell, H., Lips, K., Volk, C., 2007. Polyspeciﬁc organic cation transporters: structure,
function, physiological roles, and biopharmaceutical implications. Pharm. Res. 24,
1227–1251.
Köhler, A., Lauritzen, B., Banns, S., 1998. Clonal adaptation of cancer cells in ﬂatﬁsh liver to
environmental contamination by changes in expression of P-gp related MXR,
CYP450, GST-A and G6PDH activity. Mar. Environ. Res. 46, 191–195.
Kok, T., Bloks, V.W., Wolters, H., Havinga, R., Jansen, P.L.M., Staels, B., Kuipers, F., 2003.
Perxisome proliferator-activated receptor a (PPARa)-mediated regulation of multi-
drug resistance 2 (Mdr2) expression and function in mice. Biochem. J. 369, 539–547.
Krasowski, M.D., Yasuda, K., Hagey, L.R., Schuetz, E.G., 2005. Evolution of the pregnane x
receptor: adaptation to cross-species differences in biliary bile salts. Mol. Endocrinol.
19, 1720–1739.
Krasowski, M.D., Ai, N., Hagey, L.R., Kollitz, E.M., Kullman, S.W., Reschly, E.J., Ekins, S.,
2011. The evolution of farnesoid X, vitamin D, and pregnane X receptors: insights
from the green-spotted pufferﬁsh (Tetraodon nigriviridis) and other non-mammalian
species. BMC Biochem. 12, 5.
Krishnamurthy, P., Schuetz, J.D., 2006. Role of ABCG2/BCRP in biology and medicine.
Annu. Rev. Pharmacol. Toxicol. 46, 381–410.
Kruh, G.D., Belinsky, M.G., Gallo, J.M., Lee, K., 2007. Physiological and pharmacological
functions of Mrp2, Mrp3 and Mrp4 as determined from recent studies on gene-
disrupted mice. Cancer Metastasis Rev. 26, 5–14.
Kurelec, B., 1992. The multixenobiotic resistance mechanism in aquatic organisms. Crit.
Rev. Toxicol. 22, 12–43.
Kurelec, B., Pivčević, B., 1989. Distinct glutathione-dependent enzyme activities and a
verapamil-sensitive binding of xenobiotics in a fresh-water mussel Anodonta cygnea.
Biochem. Biophys. Res. Commun. 164, 934–940.
Kurelec, B., Pivcevic, B., 1991. Evidence for a multixenobiotic resistance mechanism in the
mussel, Mytilus galloprovincialis. Aquat. Toxicol. 19, 291–302.
Kurelec, B., Lucic, D., Pivcevic, B., Krca, S., 1995. Induction and reversion ofmultixenobiotic
resistance in the marine snail Monodonta turbinata. Mar. Biol. 123, 305–312.
Lagas, J.S., Vlaming, M.L.H., Schinkel, A.H., 2009. Pharmacokinetic assessment of multiple
ATP-binding cassette transporters: the power of combination knockout mice. Mol.
Interv. 9, 136–145.
Lanning, C.L., Sachs, C.W., Rao, U.S., Corcoran, J.J., Abou-Donia, M.B., Fine, R.L., 1996.
Chlorpyrifos oxon interacts with the mammalian multidrug resistance protein,
P-glycoprotein. J. Toxicol. Environ. Health 47, 395–407.
Leaver, M.J., Boukouvala, E., Antonopoulou, E., Diez, A., Favre-Krey, L., Ezaz, M.T., Bautista,
J.M., Tocher, D.R., Krey, G., 2005. Three peroxisome proliferator-activated receptor
isotypes from each of two species of marine ﬁsh. Endocrinology 146, 3150–3162.
Lech, J., Pepple, S., Statham, C., 1973. Fish bile analysis - possible aid in monitoring water-
quality. Toxicol. Appl. Pharmacol. 25, 430–434.
Leggas, M., Adachi, M., Scheffer, G.L., Wielinga, P., Du, G., Mercer, K.E., Panetta, J.C.,
Johnston, B., Scheper, R.J., Stewart, C.F., Schuetz, J.D., Sun, D., Zhuang, Y., 2004. Mrp4
confers resistance to topotecan and protects the brain from chemotherapy. Mol.
Cell. Biol. 24, 7612–7621.
Leier, I., Jedlitschky, G., Buchholz, U., Cole, S.P., Deeley, R.G., Keppler, D., 1994. The MRP
gene encodes an ATP-dependent export pump for leukotriene C4 and structurally
related conjugates. J. Biol. Chem. 269, 27807–27810.
Leslie, E.M., Deeley, R.G., Cole, S.P.C., 2005. Multidrug resistance proteins: role of
P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol. Appl.
Pharmacol. 204, 216–237.
Li, Q., Sadowski, S., Frank, M., Chai, C., Váradi, A., Ho, S.-Y., Lou, H., Dean, M., Thisse, C.,
Thisse, B., Uitto, J., 2010. The abcc6a gene expression is required for normal zebraﬁsh
development. J. Invest. Dermatol. 130, 2561–2568.
Litman, T., Zeuthen, T., Skovsgaard, T., Stein, W.D., 1997. Structure–activity relationships
of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase
activity. Biochim. Biophys. Acta Mol. Basis Dis. 1361, 159–168.
Liu, S., Li, Q., Liu, Z., 2013. Genome-wide identiﬁcation, characterization and phylogenetic
analysis of 50 catﬁsh ATP-binding cassette (ABC) transporter genes. PLoS One 8,
e63895.
Loncar, J., Popović, M., Zaja, R., Smital, T., 2010. Gene expression analysis of the ABC efﬂux
transporters in rainbow trout (Oncorhynchus mykiss). Comp. Biochem. Physiol. C
Toxicol. Pharmacol. 151, 209–215.
Long, Y., Li, Q., Cui, Z., 2011a. Molecular analysis and heavy metal detoxiﬁcation of
ABCC1/MRP1 in zebraﬁsh. Mol. Biol. Rep. 38, 1703–1711.
50 T. Luckenbach et al. / Comparative Biochemistry and Physiology, Part C 165 (2014) 28–52Long, Y., Li, Q., Li, J., Cui, Z., 2011b. Molecular analysis, developmental function and heavy
metal-induced expression of ABCC5 in zebraﬁsh. Comp. Biochem. Physiol. B Biochem.
Mol. Biol. 158, 46–55.
Long, Y., Li, Q., Wang, Y., Cui, Z., 2011c. MRP proteins as potential mediators of heavy
metal resistance in zebraﬁsh cells. Comp. Biochem. Physiol. C Toxicol. Pharmacol.
153, 310–317.
Long, Y., Li, Q., Zhong, S., Wang, Y., Cui, Z., 2011d.Molecular characterization and functions
of zebraﬁsh ABCC2 in cellular efﬂux of heavy metals. Comp. Biochem. Physiol. C
Toxicol. Pharmacol. 153, 381–391.
Loo, T.W., Clarke, D.M., 1998. Nonylphenol ethoxylates, but not nonylphenol, are
substrates of the human multidrug resistance P-glycoprotein. Biochem. Biophys.
Res. Commun. 247, 478–480.
Lynagh, T., Lynch, J.W., 2012. Ivermectin binding sites in human and invertebrate Cys-
loop receptors. Trends Pharmacol. Sci. 33, 432–441.
Maglich, J.M., 2003. The ﬁrst completed genome sequence from a teleost ﬁsh (Fugu
rubripes) adds signiﬁcant diversity to the nuclear receptor superfamily. Nucleic
Acids Res. 31, 4051–4058.
Maglich, J.M., Stoltz, C.M., Goodwin, B., Hawkins-Brown, D., Moore, J.T., Kliewer, S.A., 2002.
Nuclear pregnane X receptor and constitutive androstane receptor regulate overlap-
ping but distinct sets of genes involved in xenobiotic detoxiﬁcation. Mol. Pharmacol.
62, 638–646.
Marshall, W.S., Grosell, M., 2006. Ion transport, osmoregulation, and acid-base balance. In:
Evans, D.H., Claiborne, J.B. (Eds.), The Physiology of Fishes. CRC Press, Boca Raton, FL,
USA, pp. 177–230.
Masereeuw, R., Russel, F.G.M., 2012. Regulatory pathways for ATP-binding cassette trans-
port proteins in kidney proximal tubules. AAPS J. 14, 883–894.
Masereeuw, R., Russel, F.G.M., Miller, D.S., 1996. Multiple pathways of organic anion se-
cretion in renal proximal tubule revealed by confocal microscopy. Am. J. Physiol.
271, F1173–F1182.
Masereeuw, R., Moons, M.M., Toomey, B.H., Russel, F.G.M., Miller, D.S., 1999. Active lucifer
yellow secretion in renal proximal tubule: evidence for organic anion transport
system crossover. J. Pharmacol. Exp. Ther. 289, 1104–1111.
Masereeuw, R., Terlouw, S.A., van Aubel, R.A., Russel, F.G.M., Miller, D.S., 2000. Endothelin
B receptor-mediated regulation of ATP-driven drug secretion in renal proximal tu-
bule. Mol. Pharmacol. 57, 59–67.
McKim, J.M., 1985. Early life stage toxicity tests. In: Rand, G.M., Petrocelli, S.R. (Eds.),
Fundamentals of Aquatic Toxicology. Hemisphere, New York, pp. 58–95.
Miller, D.S., 1987. Aquatic models for the study of renal transport function and pollutant
toxicity. Environ. Health Perspect. 71, 59–68.
Miller, D.S., 1995. Daunomycin secretion by killﬁsh renal proximal tubules. Am. J. Physiol.
Regul. Integr. Comp. Physiol. 269, R370–R379.
Miller, D.S., 2010. Regulation of P-glycoprotein and other ABC drug transporters at the
blood–brain barrier. Trends Pharmacol. Sci. 31, 246–254.
Miller, D.S, Masereeuw, R., Karnaky, K.J., 2002. Regulation of MRP2-mediated transport in
shark rectal salt gland tubules. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282,
R774–R781.
Miller, D.S., Pritchard, J.B., 1997. Dual pathways for organic anion secretion in renal
proximal tubule. J. Exp. Zool. 279, 462–470.
Miller, D.S., Fricker, G., Drewe, J., 1997. p-Glycoprotein-mediated transport of a ﬂuorescent
rapamycin derivative in renal proximal tubule. J. Pharmacol. Exp. Ther. 282, 440–444.
Miller, D.S., Masereeuw, R., Henson, J., Karnaky, K.J., 1998a. Excretory transport of xenobi-
otics by dogﬁsh shark rectal gland tubules. Am. J. Physiol. 275, R697–R705.
Miller, D.S., Sussman, C.R., Renfro, J.L., 1998b. Protein kinase C regulation of p-
glycoprotein-mediated xenobiotic secretion in renal proximal tubule. Am. J. Physiol.
275, F785–F795.
Miller, D.S., Graeff, C., Droulle, L., Fricker, S., Fricker, G., 2002. Xenobiotic efﬂux pumps in
isolated ﬁsh brain capillaries. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282,
R191–R198.
Miller, D.S., Shaw, J.R., Stanton, C.R., Barnaby, R., Karlson, K.H., Hamilton, J.W., Stanton, B.A.,
2007. MRP2 and acquired tolerance to inorganic arsenic in the kidney of killiﬁsh
(Fundulus heteroclitus). Toxicol. Sci. 97, 103–110.
Mirbahai, L., Yin, G., Bignell, J.P., Li, N.,Williams, T.D., Chipman, J.K., 2011. DNAmethylation
in liver tumorigenesis in ﬁsh from the environment. Epigenetics 6, 1319–1333.
Moitra, K., Scally, M., McGee, K., Lancaster, G., Gold, B., Dean, M., 2011. Molecular evolu-
tionary analysis of ABCB5: the ancestral gene is a full transporter with potentially
deleterious single nucleotide polymorphisms. PLoS One 6, e16318.
Moore, L.B., Parks, D.J., Jones, S.A., Bledsoe, R.K., Consler, T.G., Stimmel, J.B., Goodwin, B.,
Liddle, C., Blanchard, S.G., Willson, T.M., Collins, J.L., Kliewer, S.A., 2000. Orphan
nuclear receptors constitutive androstane receptor and pregnane X receptor share
xenobiotic and steroid ligands. J. Biol. Chem. 275, 15122–15127.
Moore, L.B., Maglich, J.M., McKee, D.D., Wisely, B., Willson, T.M., Kliewer, S.A.,
Lambert, M.H., Moore, J.T., 2002. Pregnane X receptor (PXR), constitutive
androstane receptor (CAR), and benzoate X receptor (BXR) deﬁne three pharma-
cologically distinct classes of nuclear receptors. Mol. Endocrinol. 16, 977–986.
Moschetta, A., Xu, F., Hagey, L.R., van Berge-Henegouwen, G.P., van Erpecum, K.J.,
Brouwers, J.F., Cohen, J.C., Bierman, M., Hobbs, H.H., Steinbach, J.H., Hofmann, A.F.,
2005. A phylogenetic survey of biliary lipids in vertebrates. J. Lipid Res. 46,
2221–2232.
Mruk, D.D., Su, L., Cheng, C.Y., 2011. Emerging role for drug transporters at the blood-
testis barrier. Trends Pharmacol. Sci. 32, 99–106.
Myers, M.S., Landahl, J.T., Krahn, M.M., McCain, B.B., 1991. Relationships between hepatic
neoplasms and related lesions and exposure to toxic chemicals in marine ﬁsh from
the U.S. West Coast. Environ. Health Perspect. 90, 7–15.
Nebert, D.W., Roe, A.L., Dieter, M.Z., Solis, W.A., Yang, Y., Dalton, T.P., 2000. Role of the ar-
omatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response,
cell cycle control, and apoptosis. Biochem. Pharmacol. 59, 65–85.Nelson, G., 2006. Fishes of the world, 4th ed. Wiley, New York,.
Nichols, J., Erhardt, S., Dyer, S., James, M., Noore, M., Plotzke, K., Segner, H., Schultz, I.,
Thomas, K., Vasiluk, L., Weisbrod, A., 2007. Use of in vitro absorption, distribution,
metabolism, and excretion (ADME) data in bioaccumulation assessments for ﬁsh.
Hum. Ecol. Risk. Assess. 13, 1164–1191.
Nickel, S., Bernd, A., Miller, D.S., Fricker, G., Mahringer, A., 2013. Bisphenol - A modulates
function of ABC transporters in killiﬁsh. MDIBL Bull. 52, 30.
Nies, A.T., Keppler, D., 2007. The apical conjugate efﬂux pump ABCC2 (MRP2). Pﬂugers
Arch. 453, 643–659.
Notenboom, S., Miller, D.S., Smits, P., Russel, F.G.M., Masereeuw, R., 2002. Role of NO in
endothelin-regulated drug transport in the renal proximal tubule. Am. J. Physiol.
Ren. Physiol. 282, F458–F464.
Notenboom, S., Miller, D.S., Smits, P., Russel, F.G.M., Masereeuw, R., 2004. Involvement of
guanylyl cyclase and cGMP in the regulation of Mrp2-mediated transport in the
proximal tubule. Am. J. Physiol. Ren. Physiol. 287, F33–F38.
Notredame, C., Higgins, D.G., Heringa, J., 2000. T-Coffee: A novel method for fast and accu-
rate multiple sequence alignment. J. Mol. Biol. 302, 205–217.
Oberemm, A., 2000. The use of a reﬁned zebraﬁsh embryo bioassay for the assessment of
aquatic toxicity. LAB Anim. York 29, 32–43.
Ohno, S., 1970. Evolution by gene duplication. Springer, New York,.
Oikari, A., Kunnamo-Ojala, T., 1987. Tracing of xenobiotic contamination inwaterwith the
aid of ﬁsh bile metabolites: a ﬁeld study with caged rainbow trout (Salmo gairdneri).
Aquat. Toxicol. 9, 327–341.
Ono, N., Van Der Heijden, I., Scheffer, G.L., Van DeWetering, K., Van Deemter, E., De Haas,
M., Boerke, A., Gadella, B.M., De Rooij, D.G., Neefjes, J.J., Groothuis, T.A.M., Oomen, L.,
Ishikawa, T., Borst, P., 2007. Multidrug resistance-associated protein 9 (ABCC12) is
present in mouse and boar sperm. Biochem. J. 406, 31–40.
Oostendorp, R.L., Beijnen, J.H., Schellens, J.H.M., 2009. The biological and clinical role of
drug transporters at the intestinal barrier. Cancer Treat. Rev. 35, 137–147.
Oosterhuis, B., Vukman, K., Vági, E., Glavinas, H., Jablonkai, I., Krajcsi, P., 2008. Speciﬁc
interactions of chloroacetanilide herbicides with human ABC transporter proteins.
Toxicology 248, 45–51.
Oude Elferink, R.P.J., Paulusma, C.C., 2007. Function and pathophysiological importance of
ABCB4 (MDR3 P-glycoprotein). Pﬂugers Arch. 453, 601–610.
Oude Elferink, R.P.J., Ottenhoff, R., Fricker, G., Seward, D.J., Ballatori, N., Boyer, J., 2004. Lack
of biliary lipid excretion in the little skate, Raja erinacea, indicates the absence of
functional Mdr2, Abcg5, and Abcg8 transporters. Am. J. Physiol. Gastrointest. Liver
Physiol. 286, G762–G768.
Paetzold, S.C., Ross, N.W., Richards, R.C., Jones, M., Hellou, J., Bard, S.M., 2009. Up-
regulation of hepatic ABCC2, ABCG2, CYP1A1 and GST in multixenobiotic-resistant
killiﬁsh (Fundulus heteroclitus) from the Sydney Tar Ponds, Nova Scotia, Canada.
Mar. Environ. Res. 68, 37–47.
Park, D., Haldi, M., Seng, W.L., 2012. Zebraﬁsh: a new in vivo model for identifying P-
glycoprotein efﬂux modulators. In: McGrath, P. (Ed.), Zebraﬁsh: Methods for
Assessing Drug Safety and Toxicity. Wiley, Hoboken, NJ, USA, pp. 177–190.
Pfendner, E.G., Vanakker, O.M., Terry, S.F., Vourthis, S., McAndrew, P.E., McClain, M.R.,
Fratta, S., Marais, A.-S., Hariri, S., Coucke, P.J., Ramsay, M., Viljoen, D., Terry, P.F., De
Paepe, A., Uitto, J., Bercovitch, L.G., 2007. Mutation detection in the ABCC6 gene and
genotype–phenotype analysis in a large international case series affected by
pseudoxanthoma elasticum. J. Med. Genet. 44, 621–628.
Polli, J.W., Jarrett, J.L., Studenberg, S.D., Humphreys, J.E., Dennis, S.W., Brouwer, K.R.,
Woolley, J.L., 1999. Role of P-glycoprotein on the CNS disposition of amprenavir
(141 W94), an HIV protease inhibitor. Pharm. Res. 16, 1206–1212.
Polli, J.W., Wring, S.A., Humphreys, J.E., Huang, L., Morgan, J.B., Webster, L.O., Serabjit-
Singh, C.S., 2001. Rational use of in vitro P-glycoprotein assays in drug discovery. J.
Pharmacol. Exp. Ther. 299, 620–628.
Popovic, M., Zaja, R., Loncar, J., Smital, T., 2010. A novel ABC transporter: the ﬁrst insight
into zebraﬁsh (Danio rerio) ABCH1. Mar. Environ. Res. 69, S11–S13 (Suppl.).
Prevoo, B., Miller, D.S., Van DeWater, F.M.,Wever, K.E., Russel, F.G.M., Flik, G., Masereeuw,
R., 2011. Rapid, nongenomic stimulation of multidrug resistance protein 2 (Mrp2)
activity by glucocorticoids in renal proximal tubule. J. Pharmacol. Exp. Ther. 338,
362–371.
Rebbeor, J.F., Connolly, G.C., Henson, J.H., Boyer, J.L., Ballatori, N., 2000. ATP-dependent
GSH and glutathione S -conjugate transport in skate liver: role of an Mrp functional
homologue ATP-dependent GSH and glutathione S-conjugate transport in skate
liver: role of an Mrp functional homologue. Am. J. Physiol. Gastrointest. Liver Physiol.
279, G417–G425.
Redzic, Z., 2011. Molecular biology of the blood–brain and the blood–cerebrospinal ﬂuid
barriers: similarities and differences. Fluids Barriers CNS 8, 3.
Reichel, V., Masereeuw, R., van den Heuvel, J.J.M.W., Miller, D.S., Fricker, G., 2007.
Transport of a ﬂuorescent cAMP analog in teleost proximal tubules. Am. J. Physiol.
Regul. Integr. Comp. Physiol. 293, R2382–R2389.
Reichel, V., Miller, D.S., Fricker, G., 2008. Texas Red transport across rat and dogﬁsh shark
(Squalus acanthias) choroid plexus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295,
R1311–R1319.
Reschly, E.J., Bainy, A.C.D., Mattos, J.J., Hagey, L.R., Bahary, N., Mada, S.R., Ou, J.,
Venkataramanan, R., Krasowski, M.D., 2007. Functional evolution of the vitamin D
and pregnane X receptors. BMC Evol. Biol. 7, 222.
Reschly, E.J., Ai, N., Ekins, S., Welsh, W.J., Hagey, L.R., Hofmann, A.F., Krasowski, M.D., 2008.
Evolution of the bile salt nuclear receptor FXR in vertebrates. J. Lipid Res. 49, 1577–1587.
Riordan, J.R., Ling, V., 1985. Genetic and biochemical characterization of multidrug resis-
tance. Pharmacol. Ther. 28, 51–75.
Riordan, J.R., Rommens, J.M., Kerem, B.S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J.,
Lok, S., Plavsic, N., Chou, J.L., Drumm, M.L., Ianuzzi, M.C., Collins, F.S., Tsui, L.C., 1989.
Identiﬁcation of the cystic ﬁbrosis gene: cloning and characterization of complemen-
tary DNA. Science 245, 1066–1073.
51T. Luckenbach et al. / Comparative Biochemistry and Physiology, Part C 165 (2014) 28–52Robey, R.W., Steadman, K., Polgar, O., Morisaki, K., Blayney, M., Mistry, P., Bates, S.E., 2004.
Pheophorbide a is a speciﬁc probe for ABCG2 function and inhibition. Cancer Res. 64,
1242–1246.
Robey, R.W., To, K.K.K., Polgar, O., Dohse, M., Fetsch, P., Dean, M., Bates, S.E., 2009. ABCG2:
a perspective. Adv. Drug Deliv. Rev. 61, 3–13.
Robinson-Rechavi, M., Marchand, O., Escriva, H., Bardet, P.L., Zelus, D., Hughes, S., Laudet,
V., 2001. Euteleost ﬁsh genomes are characterized by expansion of gene families.
Genome Res. 11, 781–788.
Roma, M.-G., 2008. Dynamic localization of hepatocellular transporters in health and
disease. World J. Gastroenterol. 14, 6786.
Roninson, I.B., Abelson, A.T., Housman, D., Howell, N., Varshavsky, A., 1984. Ampliﬁcation
of speciﬁc DNA sequences correlates with multi-drug resistance in Chinese hamster
cells. Nature 309, 626–628.
Rotchell, J.M., Miller, M.R., Hinton, D.E., Di Giulio, R.T., Ostrander, G.K., 2008. Chemical
carcinogenesis in ﬁshes. In: Di Giulio, R.T., Hinton, David E. (Eds.), The Toxicology of
Fishes. CRC Press, Boca Raton, FL, USA, pp. 531–596.
Sabri, D.M., Rabie, T., Ahmed, A.I., Zakaria, S., Bourdineaud, J.-P., 2012. Heavy metals-
induced expression of ABCB10 gene in zebraﬁsh Danio rerio. Egypt. Acad. J. Biol. Sci.
4, 97–106.
Saito, Y., Wright, E.M., 1984. Regulation of bicarbonate transport across the brush border
membrane of the bull frog choroid plexus. J. Physiol. 350, 327–342.
Sarkadi, B., Price, E.M., Boucher, R.C., Germann, U.A., Scarborough, G.A., 1992. Expression
of the human multidrug resistance cDNA in insect cells generates a high activity
drug-stimulated membrane ATPase. J. Biol. Chem. 267, 4854–4858.
Sauerborn Klobučar, R., Zaja, R., Franjević, D., Brozović, A., Smital, T., 2010. Presence of
ecotoxicologically relevant Pgp and MRP transcripts and proteins in cyprinid ﬁsh.
Arh. Hig. Rada Toksikol. 61, 175–182.
Schinkel, A.H., Jonker, J.W., 2003. Mammalian drug efﬂux transporters of the ATP binding
cassette (ABC) family: an overview. Adv. Drug Deliv. Rev. 55, 3–29.
Schinkel, A.H., Smit, J.J., van Tellingen, O., Beijnen, J.H., Wagenaar, E., van Deemter, L.,
Mol, C.A., van der Valk, M.A., Robanus-Maandag, E.C., te Riele, H.P., Berns, A.J.M.,
Borst, P., 1994. Disruption of the mouse mdr1a P-glycoprotein gene leads to a de-
ﬁciency in the blood–brain barrier and to increased sensitivity to drugs. Cell 77,
491–502.
Schinkel, A.H., Wagenaar, E., van Deemter, L., Mol, C.A.A.M., Borst, P., 1995. Absence of the
mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of
dexamethasone, digoxin, and cyclosporin A. J. Clin. Invest. 96, 1698–1705.
Schlenk, D., Celander, M., Gallagher, E., George, S., James, M., Kullman, S.W., Van den Hurk,
P., Willett, K., 2008. Biotransformation in ﬁshes. In: Di Giulio, R., Hinton, D.E. (Eds.),
The Toxicology of Fishes. CRC Press, Boca Raton, FL, USA, pp. 153–234.
Schramm, U., Fricker, G., Wenger, R., Miller, D.S., 1995. P-glycoprotein-mediated secretion
of a ﬂuorescent cyclosporin analogue by teleost renal proximal tubules. Am. J. Physiol.
Physiol. 268, F46–F52.
Scotto, K.W., 2003. Transcriptional regulation of ABC drug transporters. Oncogene 22,
7496–7511.
Sharom, F.J., Yu, X., Lu, P., Liu, R., Chu, J.W., Szabó, K., Müller, M., Hose, C.D., Monks, A.,
Váradi, A., Seprôdi, J., Sarkadi, B., 1999. Interaction of the P-glycoprotein multi-
drug transporter (MDR1) with high afﬁnity peptide chemosensitizers in isolated
membranes, reconstituted systems, and intact cells. Biochem. Pharmacol. 58,
571–586.
Shepard, R.L., Cao, J., Starling, J.J., Dantzig, A.H., 2003.Modulation of P-glycoprotein but not
MRP1- or BCRP-mediated drug resistance by LY335979. Int. J. Cancer 125, 121–125.
Shúilleabháin, S.N., Davoren, M., Mothersill, C., Sheehan, D., Hartl, M.G.J., Kilemade, M.,
O'brien, N.M., O'halloran, J., Van Pelt, F.N.A.M., Lyng, F.M., 2005. Identiﬁcation of
a multixenobiotic resistance mechanism in primary cultured epidermal cells from
Oncorhynchus mykiss and the effects of environmental complex mixtures on its
activity. Aquat. Toxicol. 73, 115–127.
Siegsmund, M.J., Cardarelli, C., Aksentijevich, I., Sugimoto, Y., Pastan, I., Gottesman, M.M.,
1994. Ketoconazole effectively reverses multidrug resistance in highly resistant KB
cells. J. Urol. 151, 485–491.
Slot, A.J., Molinski, S.V., Cole, S.P.C., 2011. Mammalian multidrug resistance proteins
(MRPs). Essays Biochem. 50, 179–207.
Small, H.J., Williams, T.D., Sturve, J., Chipman, J.K., Southam, A.D., Bean, T.P., Lyons, B.P.,
Stentiford, G.D., 2010. Gene expression analyses of hepatocellular adenoma and
hepatocellular carcinoma from the marine ﬂatﬁsh Limanda limanda. Dis. Aquat. Org.
88, 127–141.
Smital, T., Sauerborn, R., 2002. Measurement of the activity of multixenobiotic resistance
mechanism in the common carp Cyprinus carpio. Mar. Environ. Res. 54, 449–453.
Smital, T., Terzic, S., Zaja, R., Senta, I., Pivcevic, B., Popovic, M., Mikac, I., Tollefsen, K.E.,
Thomas, K.V., Ahel, M., 2011. Assessment of toxicological proﬁles of the municipal
wastewater efﬂuents using chemical analyses and bioassays. Ecotoxicol. Environ.
Saf. 74, 844–851.
Stein, W.D., 1997. Kinetics of the multidrug transporter and its reversal. Physiol. Rev. 77,
545–590.
Steinke, D., Hoegg, S., Brinkmann, H., Meyer, A., 2006. Three rounds (1R/2R/3R) of
genome duplications and the evolution of the glycolytic pathway in vertebrates.
BMC Biol. 4, 16.
Stieger, B., Meier, Y., Meier, P.J., 2007. The bile salt export pump. Pﬂugers Arch. 453, 611–620.
Sturm, A., Segner, H., 2005. P-glycoproteins and xenobiotic efﬂux transport in ﬁsh.
Biochem. In: Mommsen, T.P., Moon, T.W. (Eds.), Mol. Biol. Fishes 6, 495–533.
Sturm, A., Cravedi, J.P., Segner, H., 2001a. Prochloraz and nonylphenol diethoxylate inhibit
anmdr1-like activity in vitro, but do not alter hepatic levels of P-glycoprotein in trout
exposed in vivo. Aquat. Toxicol. 53, 215–228.
Sturm, A., Ziemann, C., Hirsch-Ernst, K.I., Segner, H., 2001b. Expression and functional
activity of P-glycoprotein in cultured hepatocytes from Oncorhynchus mykiss. Am. J.
Physiol. Regul. Integr. Comp. Physiol. 281, R1119–R1126.Sussman-Turner, C., Renfro, J.L., 1995. Heat-shock stimulated transepithelial daunomycin
secretion by ﬂounder renal proximal tubule primary cultures. Am. J. Physiol. 268,
F135–F144.
Synold, T.W., Dussault, I., Forman, B.M., 2001. The orphan nuclear receptor SXR coordi-
nately regulates drug metabolism and efﬂux. Nat. Med. 7, 584–590.
Szakács, G., Váradi, A., Ozvegy-Laczka, C., Sarkadi, B., 2008. The role of ABC transporters in
drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Drug
Discov. Today 13, 379–393.
Szatmari, I., Vámosi, G., Brazda, P., Balint, B.L., Benko, S., Széles, L., Jeney, V., Ozvegy-
Laczka, C., Szántó, A., Barta, E., Balla, J., Sarkadi, B., Nagy, L., 2006. Peroxisome
proliferator-activated receptor gamma-regulated ABCG2 expression confers
cytoprotection to human dendritic cells. J. Biol. Chem. 281, 23812–23823.
Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M., Kumar, S., 2011. MEGA5: molec-
ular evolutionary genetics analysis using maximum likelihood, evolutionary distance,
and maximum parsimony methods. Mol. Biol. Evol. 28, 2731–2739.
Tan, X., Yim, S.-Y., Uppu, P., Kleinow, K.M., 2010. Enhanced bioaccumulation of dietary
contaminants in catﬁsh with exposure to the waterborne surfactant linear
alkylbenzene sulfonate. Aquat. Toxicol. 99, 300–308.
Taylor, J.S., Van de Peer, Y., Braasch, I., Meyer, A., 2001. Comparative genomics provides
evidence for an ancient genome duplication event in ﬁsh. Philos. Trans. R. Soc.
Lond. B Biol. Sci. 356, 1661–1679.
Teeter, L.D., Petersen, D.D., Nebert, D.W., Kuo, M.T., 1991. Murine mdr1-1, mdr-2, and
mdr-3 gene expression: no coinduction with the Cyp1a-1 and Nmo-1 genes in liver
by 2,3,7,8-tetrachlorodibenzo-p-dioxin. DNA Cell Biol. 10, 433–441.
Terlouw, S.A., Masereeuw, R., Russel, F.G., Miller, D.S., 2001. Nephrotoxicants induce
endothelin release and signaling in renal proximal tubules: effect on drug efﬂux.
Mol. Pharmacol. 59, 1433–1440.
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M.M., Pastan, I., 1987. Cellular localization
of the multidrug-resistance gene product in normal human tissues. Proc. Natl. Acad.
Sci. U. S. A. 84, 7735–7738.
Thisse, B., Thisse, C., 2004. Fast release clones: a high throughput expression analysis. ZFIN
direct data submission, ([WWW Document]. URL http://zﬁn.org/cgi-bin/webdriver?
MIval=aa-xpatselect.apg&query_results=true&gene_name=abcb5&searchtype=
equals).
Tutundjian, R., Cachot, J., Leboulenger, F., Minier, C., 2002. Genetic and immunological
characterisation of a multixenobiotic resistance system in the turbot (Scophthalmus
maximus). Comp. Biochem. Physiol. B Biochem. Mol. Biol. 132, 463–471.
Twentyman, P.R., Rhodes, T., Rayner, S., 1994. A comparison of rhodamine 123 accumula-
tion and efﬂux in cells with P-glycoprotein-mediated and MRP-associated multidrug
resistance phenotypes. Eur. J. Cancer 30A, 1360–1369.
Ueda, K., Cardarelli, C., Gottesman, M.M., Pastan, I., 1987. Expression of a full-length cDNA
for the human “MDR1” gene confers resistance to colchicine, doxorubicin, and
vinblastine. Proc. Natl. Acad. Sci. U. S. A. 84, 3004–3008.
Ueno, M., 2009. Mechanisms of the penetration of blood-borne substances into the brain.
Curr. Neuropharmacol. 7, 142–149.
Van Aubel, R.A.M.H., Smeets, P.H.E., Peters, J.G.P., Bindels, R.J.M., Russel, F.G.M., 2002. The
MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney
proximal tubules: putative efﬂux pump for urinary cAMP and cGMP. J. Am. Soc.
Nephrol. 13, 595–603.
Van Veen, H.W., Higgins, C.F., Konings, W.N., 2001. Multidrug transport by ATP binding
cassette transporters: a proposed two-cylinder engine mechanism. Res. Microbiol.
152, 365–374.
Vethaak, A., Jol, J., 1996. Diseases of ﬂounder Platichthys ﬂesus in Dutch coastal and
estuarine waters, with particular reference to environmental stress factors. I.
Epizootiology of gross lesions. Dis. Aquat. Org. 26, 81–97.
Vethaak, A.D., Wester, P.W., 1996. Diseases of ﬂounder Platichthys ﬂesus in Dutch coastal
and estuarine waters, with particular reference to environmental stress factors. II.
Liver histopathology. Dis. Aquat. Org. 26, 99–116.
Vlaming, M.L.H., Lagas, J.S., Schinkel, A.H., 2009. Physiological and pharmacological roles
of ABCG2 (BCRP): recent ﬁndings in Abcg2 knockout mice. Adv. Drug Deliv. Rev.
61, 14–25.
Von Richter, O., Glavinas, H., Krajcsi, P., Liehner, S., Siewert, B., Zech, K., 2009. A novel screen-
ing strategy to identify ABCB1 substrates and inhibitors. Naunyn Schmiedebergs Arch.
Pharmacol. 379, 11–26.
Wang, N., Lan, D., Chen, W., Matsuura, F., Tall, A.R., 2004. ATP-binding cassette trans-
porters G1 and G4 mediate cellular cholesterol efﬂux to high-density lipoproteins.
Proc. Natl. Acad. Sci. U. S. A. 101, 9774–9779.
Waxman, D.J., 1999. P450 gene induction by structurally diverse xenochemicals: central
role of nuclear receptors CAR, PXR, and PPAR. Arch. Biochem. Biophys. 369, 11–23.
Wever, K.E., Masereeuw, R., Miller, D.S., Hang, X.M., Flik, G., 2007. Endothelin and
calciotropic hormones share regulatory pathways in multidrug resistance protein
2-mediated transport. Am. J. Physiol. Ren. Physiol. 292, F38–F46.
Wijnholds, J., Evers, R., VanLeusden, M.R., Mol, C., Zaman, G.J.R., Mayer, U., Beijnen, J.H.,
VanderValk, M., Krimpenfort, P., Borst, P., 1997. Increased sensitivity to anticancer
drugs and decreased inﬂammatory response in mice lacking the multidrug
resistance-associated protein. Nat. Med. 3, 1275–1279.
Woodward, O.M., Köttgen, A., Köttgen, M., 2011. ABCG transporters and disease. FEBS J.
278, 3215–3225.
Wright, S.H., Dantzler, W.H., 2004. Molecular and cellular physiology of renal organic
cation and anion transport. Physiol. Rev. 84, 987–1049.
Xie,W., Yeuh,M.-F., Radominska-Pandya, A., Saini, S.P.S., Negishi, Y., Bottroff, B.S., Cabrera,
G.Y., Tukey, R.H., Evans, R.M., 2003. Control of steroid, heme, and carcinogen metab-
olism by nuclear pregnane X receptor and constitutive androstane receptor. Proc.
Natl. Acad. Sci. U. S. A. 100, 4150–4155.
Xie, J., Farage, E., Sugimoto, M., Anand-Apte, B., 2010. A novel transgenic zebraﬁsh model
for blood–brain and blood-retinal barrier development. BMC Dev. Biol. 10, 76.
52 T. Luckenbach et al. / Comparative Biochemistry and Physiology, Part C 165 (2014) 28–52Yeheskely-Hayon, D., Regev, R., Katzir, H., Eytan, G.D., 2009. Competition between innate
multidrug resistance and intracellular binding of rhodamine dyes. FEBS J. 276,
637–648.
Yudt, M.R., Cidlowski, J.A., 2002. The glucocorticoid receptor: coding a diversity of
proteins and responses through a single gene. Mol. Endocrinol. 16, 1719–1726.
Zaja, R., Klobucar, R.S., Smital, T., 2007. Detection and functional characterization of Pgp1
(ABCB1) andMRP3 (ABCC3) efﬂux transporters in the PLHC-1 ﬁsh hepatoma cell line.
Aquat. Toxicol. 81, 365–376.
Zaja, R., Caminada, D., Lončar, J., Fent, K., Smital, T., 2008a. Development and characteriza-
tion of P-glycoprotein 1 (Pgp1, ABCB1) -mediated doxorubicin-resistant PLHC-1
hepatoma ﬁsh cell line. Toxicol. Appl. Pharmacol. 227, 207–218.
Zaja, R., Munic, V., Klobučar, R.S., Ambriovic-Ristov, A., Smital, T., 2008b. Cloning and
molecular characterization of apical efﬂux transporters (ABCB1, ABCB11 and
ABCC2) in rainbow trout (Oncorhynchus mykiss) hepatocytes. Aquat. Toxicol. 90,
322–332.Zaja, R., Lončar, J., Popovic, M., Smital, T., 2011. First characterization of ﬁsh P-glycoprotein
(abcb1) substrate speciﬁcity using determinations of its ATPase activity and calcein-
AM assay with PLHC-1/dox cell line. Aquat. Toxicol. 103, 53–62.
Zaja, R., Terzić, S., Senta, I., Lončar, J., Popović, M., Ahel, M., Smital, T., Terzić, S., 2013. Iden-
tiﬁcation of P-glycoprotein inhibitors in contaminated freshwater sediments. Environ.
Sci. Technol. 47, 4813–4821.
Zaman, G.J., Flens, M.J., van Leusden, M.R., de Haas, M., Mülder, H.S., Lankelma, J., Pinedo,
H.M., Scheper, R.J., Baas, F., Broxterman, H.J., 1994. The human multidrug resistance-
associated protein MRP is a plasma membrane drug-efﬂux pump. Proc. Natl. Acad.
Sci. U. S. A. 91, 8822–8826.
Zhu, M., Zhao, W., Jia, L., Lu, J., Qiao, T., Qu, Q., 2009. The oldest articulated osteichthyan
reveals mosaic gnathostome characters. Nature 458, 469–474.
Zucchi, S., Corsi, I., Luckenbach, T., Mala, S., Regoli, F., Focardi, S., 2010. Identiﬁcation of ﬁve
partial ABC genes in the liver of the Antarctic ﬁsh Trematomus bernacchii and sensitiv-
ity of ABCB1 and ABCC2 to Cd exposure. Environ. Pollut. 158, 2746–2756.
